Insulet Corporation
(NASDAQ:PODD)

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as wireless companion, the handheld...

Website: http://www.insulet.com

Founded: 2000

Full Time Employees: 1,350

CEO: Shacey Petrovic

Sector: Healthcare

Industry: Medical Devices

Medical Devices Diabetes

Share this website to your friends

• Market Cap:

• Exchange:

• Shs Outstanding:

• Employees:

• Beta:

• Return on Equity (ROE) ttm:

• Return on Assets (ROA) ttm:

• EPS ttm:

• Book value per Share:

• Cash per Share:

• Current ast per Share:

• P/E ttm:

• P/E forward:

• P/E ttm high:

• P/E ttm low:

• P/S ttm:

• P/B ttm:

• P/FCF ttm:

• PEG ratio:

• Cash Ratio ttm:

• Quick Ratio ttm:

• Current Ratio ttm:

• Gross Mgn ttm:

• EBITDA Mgn ttm:

• Operating Mgn ttm:

• Net Income Mgn ttm:

• Trailing Div yield:

• Forward Div yield:

• Payout Ratio ttm:

• Ex-Dividend date:

• Target Price High:

• Target Price Low:

• Target Price Mean:

• Number of Analysts:

• Debt Ratio ttm:

• Debt to Equity ttm:

• Total Net Debt:

At a glance:

Bull Thesis:

Bear Thesis:

Main Competitors:

Moat:

Income Statements:

Quarterly

Annual

Unit: USD	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31

revenue	783,800,000	521,700,000	470,500,000	420,500,000	440,100,000	372,600,000	341,200,000	329,900,000	354,100,000	320,700,000	287,300,000	261,300,000	282,600,000	281,900,000	243,900,000	247,000,000	307,700,000	275,600,000	263,200,000	252,300,000	246,100,000	234,000,000	226,300,000	198,000,000	209,394,000	192,115,000	177,136,000	159,555,000	164,907,000	151,076,000	124,262,000	123,578,000	130,524,000	121,775,000	109,756,000	101,713,000	103,575,000	94,871,000	87,330,000	81,213,000	100,119,000	87,303,000	75,588,000	61,215,000	72,561,000	74,985,000	72,013,000	69,161,000	68,533,000	61,103,000	60,092,000	57,356,000	57,828,000	54,752,000	51,035,000	47,754,000	47,192,000	44,594,000	32,211,000	28,258,000	27,767,000	25,455,000	22,937,000	20,807,000	20,211,000	18,735,000	14,617,000	12,469,000	11,861,000	10,110,000	7,417,000	6,671,000	4,361,000	3,791,000	3,212,000	2,008,000
yoy	78.10%	40.02%	37.90%	27.46%	24.29%	16.18%	18.76%	26.25%	25.30%	13.76%	17.79%	5.79%	-8.16%	2.29%	-7.33%	-2.10%	25.03%	17.78%	16.31%	27.42%	17.53%	21.80%	27.75%	24.10%	26.98%	27.16%	42.55%	29.11%	26.34%	24.06%	13.22%	21.50%	26.02%	28.36%	25.68%	25.24%	3.45%	8.67%	15.53%	32.67%	37.98%	16.43%	4.96%	-11.49%	5.88%	22.72%	19.84%	20.58%	18.51%	11.60%	17.75%	20.11%	22.54%	22.78%	58.44%	68.99%	69.96%	75.19%	40.43%	35.81%	37.39%	35.87%	56.92%	66.87%	70.40%	85.31%	97.07%	86.91%	171.98%	166.68%	130.92%	232.22%
qoq	50.24%	10.88%	11.89%	-4.45%	18.12%	9.20%	3.43%	-6.83%	10.41%	11.63%	9.95%	-7.54%	0.25%	15.58%	-1.26%	-19.73%	11.65%	4.71%	4.32%	2.52%	5.17%	3.40%	14.29%	-5.44%	8.99%	8.46%	11.02%	-3.25%	9.15%	21.58%	0.55%	-5.32%	7.18%	10.95%	7.91%	-1.80%	9.17%	8.64%	7.53%	-18.88%	14.68%	15.50%	23.48%	-15.64%	-3.23%	4.13%	4.12%	0.92%	12.16%	1.68%	4.77%	-0.82%	5.62%	7.28%	6.87%	1.19%	5.83%	38.44%	13.99%	1.77%	9.08%	10.98%	10.24%	2.95%	7.88%	28.17%	17.23%	5.13%	17.32%	36.31%	11.18%	52.97%	15.04%	18.03%	59.96%
revenue from related party		184,500,000	178,600,000	148,500,000	157,400,000	171,300,000	147,300,000	111,800,000	155,700,000	112,000,000	109,200,000	96,800,000	87,100,000	58,900,000	55,500,000	48,400,000
total revenue	783,800,000	706,300,000	649,100,000	569,000,000	597,500,000	543,900,000	488,500,000	441,700,000	509,800,000	432,700,000	396,500,000	358,100,000	369,700,000	340,800,000	299,400,000	295,400,000
cost of revenue	215,200,000	196,200,000	196,900,000	160,000,000	166,600,000	166,800,000	157,600,000	134,900,000	148,600,000	139,400,000	131,600,000	117,600,000	152,400,000	152,500,000	109,100,000	85,700,000	94,500,000	86,900,000	80,500,000	84,800,000	85,000,000	82,200,000	83,800,000	71,100,000	75,288,000	69,035,000	60,718,000	52,859,000	54,595,000	49,107,000	42,190,000	47,763,000	51,016,000	48,151,000	45,117,000	42,315,000	42,638,000	39,230,000	36,873,000	37,162,000	54,798,000	51,652,000	41,213,000	28,408,000	35,888,000	36,943,000	36,248,000	36,353,000	35,515,000	33,708,000	33,259,000	32,201,000	32,509,000	30,362,000	28,704,000	27,458,000	27,112,000	26,033,000	17,673,000	14,725,000	13,941,000	13,826,000	13,051,000	12,422,000	12,877,000	12,936,000	11,448,000	10,474,000	10,663,000	10,197,000	9,785,000	9,998,000	6,679,000	7,583,000	6,899,000	4,572,000
gross profit	568,600,000	510,100,000	452,200,000	409,000,000	430,900,000	377,100,000	330,900,000	306,800,000	361,200,000	293,300,000	264,900,000	240,500,000	217,300,000	188,300,000	190,300,000	209,700,000	213,200,000	188,700,000	182,700,000	167,500,000	161,100,000	151,800,000	142,500,000	126,900,000	134,106,000	123,080,000	116,418,000	106,696,000	110,312,000	101,969,000	82,072,000	75,815,000	79,508,000	73,624,000	64,639,000	59,398,000	60,937,000	55,641,000	50,457,000	44,051,000	45,321,000	35,651,000	34,375,000	32,807,000	36,673,000	38,042,000	35,765,000	32,808,000	33,018,000	27,395,000	26,833,000	25,155,000	25,319,000	24,390,000	22,331,000	20,296,000	20,080,000	18,561,000	14,538,000	13,533,000	13,826,000	11,629,000	9,886,000	8,385,000	7,334,000	5,799,000	3,169,000	1,995,000
yoy	31.96%	35.27%	36.66%	33.31%	19.30%	28.57%	24.92%	27.57%	66.22%	55.76%	39.20%	14.69%	1.92%	-0.21%	4.16%	25.19%	32.34%	24.31%	28.21%	31.99%	20.13%	23.33%	22.40%	18.94%	21.57%	20.70%	41.85%	40.73%	38.74%	38.50%	26.97%	27.64%	30.48%	32.32%	28.11%	34.84%	34.46%	56.07%	46.78%	34.27%	23.58%	-6.29%	-3.89%	-0.00%	11.07%	38.86%	33.29%	30.42%	30.41%	12.32%	20.16%	23.94%	26.09%	31.40%	53.60%	49.97%	45.23%	59.61%	47.06%	61.40%	88.52%	100.53%	211.96%	320.30%
qoq	11.47%	12.80%	10.56%	-5.08%	14.27%	13.96%	7.86%	-15.06%	23.15%	10.72%	10.15%	10.68%	15.40%	-1.05%	-9.25%	-1.64%	12.98%	3.28%	9.07%	3.97%	6.13%	6.53%	12.29%	-5.37%	8.96%	5.72%	9.11%	-3.28%	8.18%	24.24%	8.25%	-4.64%	7.99%	13.90%	8.82%	-2.53%	9.52%	10.27%	14.54%	-2.80%	27.12%	3.71%	4.78%	-10.54%	-3.60%	6.37%	9.01%	-0.64%	20.53%	2.09%	6.67%	-0.65%	3.81%	9.22%	10.03%	1.08%	8.18%	27.67%	7.43%	-2.12%	18.89%	17.63%	17.90%	14.33%	26.47%	82.99%	58.85%
gross margin %	72.54%	97.78%	96.11%	97.27%	97.91%	101.21%	96.98%	93.00%	102.01%	91.46%	92.20%	92.04%	76.89%	66.80%	78.02%	84.90%	69.29%	68.47%	69.41%	66.39%	65.46%	64.87%	62.97%	64.09%	64.04%	64.07%	65.72%	66.87%	66.89%	67.50%	66.05%	61.35%	60.91%	60.46%	58.89%	58.40%	58.83%	58.65%	57.78%	54.24%	45.27%	40.84%	45.48%	53.59%	50.54%	50.73%	49.66%	47.44%	48.18%	44.83%	44.65%	43.86%	43.78%	44.55%	43.76%	42.50%	42.55%	41.62%	45.13%	47.89%	49.79%	45.68%	43.10%	40.30%	36.29%	30.95%	21.68%	16.00%	0%	0%	0%	0%	0%	0%	0%	0%
research and development expenses	90,900,000	77,200,000	73,400,000	59,600,000	60,600,000	54,900,000	53,900,000	50,200,000	42,000,000	57,800,000	55,100,000	50,100,000	49,500,000	45,000,000	42,600,000	43,100,000	29,575,000	37,500,000	40,100,000	40,700,000	27,125,000	38,800,000	34,200,000	35,500,000
selling, general and administrative expenses	331,400,000	315,200,000	257,700,000	260,600,000	261,000,000	234,100,000	222,400,000	199,700,000	212,800,000	180,700,000	178,700,000	162,700,000	144,300,000	140,400,000	174,400,000	128,700,000	86,075,000	117,500,000	116,300,000	110,500,000	63,475,000	89,200,000	80,800,000	83,900,000
operating income	146,300,000	117,700,000	121,100,000	88,800,000	109,300,000	88,100,000	54,600,000	56,900,000	106,400,000	54,800,000	31,100,000	27,700,000	23,500,000	2,900,000	-26,700,000	37,900,000	49,700,000	33,700,000	26,300,000	16,300,000	-7,300,000	23,800,000	27,500,000	7,500,000	18,128,000	17,004,000	7,603,000	7,265,000	16,233,000	6,865,000	4,325,000		-768,000	2,047,000	-3,358,000	-5,308,000	-4,135,000	2,418,000	-1,288,000	-7,699,000	-24,040,000	-15,734,000	-12,361,000	-8,630,000	-2,255,000	-2,876,000	-5,280,000	-1,886,000	206,000	-17,313,000	-5,822,000	-6,206,000	-6,086,000	-8,471,000	-10,519,000	-10,895,000	-10,512,000	-9,768,000	-14,915,000	-7,273,000	-9,725,000	-8,278,000	-9,900,000	-10,730,000	-11,962,000	-13,480,000	-16,445,000	-17,472,000	-27,356,000	-19,834,000	-22,139,000	-20,012,000	-16,054,000	-14,582,000	-12,409,000	-10,798,000
yoy	33.85%	33.60%	121.79%	56.06%	2.73%	60.77%	75.56%	105.42%	352.77%	1789.66%	-216.48%	-26.91%	-52.72%	-91.39%	-201.52%	132.52%	-780.82%	41.60%	-4.36%	117.33%	-140.27%	39.97%	261.70%	3.23%	11.67%	147.69%	75.79%	NaN%	-2213.67%	235.37%	-228.80%	NaN%	-81.43%	-15.34%	160.71%	-31.06%	-82.80%	-115.37%	-89.58%	-10.79%	966.08%	447.08%	134.11%	357.58%	-1194.66%	-83.39%	-9.31%	-69.61%	-103.38%	104.38%	-44.65%	-43.04%	-42.10%	-13.28%	-29.47%	49.80%	8.09%	18.00%	50.66%	-32.22%	-18.70%	-38.59%	-39.80%	-38.59%	-56.27%	-32.04%	-25.72%	-12.69%	70.40%	36.02%	78.41%	85.33%
qoq	24.30%	-2.81%	36.37%	-18.76%	24.06%	61.36%	-4.04%	-46.52%	94.16%	76.21%	12.27%	17.87%	710.34%	-110.86%	-170.45%	-23.74%	47.48%	28.14%	61.35%	-323.29%	-130.67%	-13.45%	266.67%	-58.63%	6.61%	123.65%	4.65%	-55.25%	136.46%	58.73%	NaN%	NaN%	-137.52%	-160.96%	-36.74%	28.37%	-271.01%	-287.73%	-83.27%	-67.97%	52.79%	27.29%	43.23%	282.71%	-21.59%	-45.53%	179.96%	-1015.53%	-101.19%	197.37%	-6.19%	1.97%	-28.15%	-19.47%	-3.45%	3.64%	7.62%	-34.51%	105.07%	-25.21%	17.48%	-16.38%	-7.74%	-10.30%	-11.26%	-18.03%	-5.88%	-36.13%	37.92%	-10.41%	10.63%	24.65%	10.09%	17.51%	14.92%
operating margin %	18.67%	22.56%	25.74%	21.12%	24.84%	23.64%	16.00%	17.25%	30.05%	17.09%	10.82%	10.60%	8.32%	1.03%	-10.95%	15.34%	16.15%	12.23%	9.99%	6.46%	-2.97%	10.17%	12.15%	3.79%	8.66%	8.85%	4.29%	4.55%	9.84%	4.54%	3.48%	NaN%	-0.59%	1.68%	-3.06%	-5.22%	-3.99%	2.55%	-1.47%	-9.48%	-24.01%	-18.02%	-16.35%	-14.10%	-3.11%	-3.84%	-7.33%	-2.73%	0.30%	-28.33%	-9.69%	-10.82%	-10.52%	-15.47%	-20.61%	-22.81%	-22.27%	-21.90%	-46.30%	-25.74%	-35.02%	-32.52%	-43.16%	-51.57%	-59.19%	-71.95%	-112.51%	-140.12%	-230.64%	-196.18%	-298.49%	-299.99%	-368.13%	-384.65%	-386.33%	-537.75%
interest expense	-11,125,000	-15,600,000	-19,600,000	-9,200,000	-8,500,000	-12,300,000	-11,000,000	-10,700,000	-6,700,000	-10,400,000	-2,400,000	-2,900,000	-2,700,000	-6,800,000	-8,300,000	-8,900,000	-15,100,000	-16,300,000	-16,400,000	-13,400,000	-12,500,000	-11,400,000	-11,100,000	-10,100,000				6,615,000	6,848,000	6,846,000	7,290,000	7,918,000	6,699,000	4,709,000	4,796,000	5,007,000	5,136,000	3,029,000	3,127,000	-3,096,000	-3,145,000	-3,167,000	-3,075,000	-3,193,000	-3,180,000	-3,043,000	-3,975,000					-4,355,000	-4,066,000	-3,949,000	-3,912,000	-3,867,000	-3,732,000	-3,825,000	-4,547,000	-2,612,000	-11,192,000	-3,871,000	-3,847,000	-3,149,000	-4,354,000	-11,267,000	-3,875,000	-2,274,000	-1,019,000	-1,399,000	-2,103,000	-575,000	-611,000	-475,000	-986,000	-982,000
interest income	5,700,000	8,600,000	10,100,000	10,300,000	10,300,000	10,500,000	9,300,000	9,400,000	6,200,000	8,600,000																															30,750	46,000	41,000	36,000	37,000	32,000	29,000	31,000	33,000	27,000	37,000	27,000	27,000	31,000	24,000	28,000	32,000	31,000	39,000	37,000	59,000	49,000	36,000	24,000	51,000	22,000	81,000	101,000	388,500	481,000	360,000	713,000	608,750	1,418,000	713,000	304,000
loss on extinguishment of debt			-84,400,000	-39,500,000													-800,000	-1,500,000	-40,100,000						-2,249,000	-6,451,000
other income	3,100,000	12,100,000	1,300,000		400,000	-3,400,000			1,900,000	700,000		-200,000			-1,100,000	300,000	-400,000	-700,000	1,800,000		1,300,000	1,000,000	1,000,000		1,481,000	-53,000	1,923,000	4,054,000	1,300,500	1,834,000	1,686,000	1,682,000	369,500	556,000	488,000	434,000	315,000	211,000	129,000	170,000				5,000				265,000
income before income taxes	140,200,000	122,800,000	28,400,000	48,100,000	111,300,000	82,900,000	51,100,000	54,900,000	107,800,000	53,700,000	28,500,000	24,600,000	22,300,000	-5,700,000	-36,100,000	29,300,000	33,400,000	15,200,000	-28,400,000	300,000	-18,500,000	13,400,000	17,400,000	-2,600,000	6,782,000	1,130,000	1,884,000	4,704,000	-1,415,500	1,853,000	-1,279,000	-6,236,000									-27,187,000	-18,865,000	-15,395,000	-11,782,000	-5,396,000	-10,824,000	-29,059,000	-6,079,000	-2,654,000	-21,285,000	-10,401,000	-10,534,000	-10,125,000	-12,389,000	-14,407,000	-14,734,000
income tax benefit	-38,500,000	-35,200,000	-5,900,000		-10,600,000	-5,400,000	137,500,000		-950,000	-1,800,000	-1,200,000		25,000	500,000	1,100,000		125,000	-2,600,000	3,400,000	-300,000				500,000
net income	101,600,000	87,600,000	22,500,000	35,400,000	100,700,000	77,500,000	188,600,000	51,500,000	103,300,000	51,900,000	27,300,000	23,800,000	17,000,000	-5,200,000	-35,000,000	27,800,000	29,200,000	12,600,000	-25,000,000		-17,100,000	11,600,000	14,400,000	-2,100,000	4,968,000	852,000	1,402,000	4,378,000	9,893,000	1,659,000	-1,691,000	-6,569,000	-6,860,000	-2,227,000	-7,767,000	-9,977,000	-9,119,000	-3,081,000	-4,198,000	-12,481,000	-27,327,000	-18,927,000	-15,432,000	-11,834,000	-5,400,000	-10,845,000	-29,111,000	-6,144,000	-2,500,000	-21,290,000	-10,519,000	-10,665,000	-10,194,000	-12,417,000	-14,476,000	-14,780,000	-14,339,000	-13,562,000	-19,423,000	-9,848,000	-20,858,000	-12,100,000	-13,711,000	-13,855,000	-14,932,000	-24,725,000	-20,239,000	-19,645,000	-28,283,000	-20,752,000	-23,882,000	-19,874,000	-15,668,000	-13,639,000	-12,672,000	-11,560,000
yoy	0.89%	13.03%	-88.07%	-31.26%	-2.52%	49.33%	590.84%	116.39%	507.65%	-1098.08%	-178.00%	-14.39%	-41.78%	-141.27%	40.00%	NaN%	-270.76%	8.62%	-273.61%	NaN%	-444.20%	1261.50%	927.10%	-147.97%	-49.78%	-48.64%	-182.91%	-166.65%	-244.21%	-174.49%	-78.23%	-34.16%	-24.77%	-27.72%	85.02%	-20.06%	-66.63%	-83.72%	-72.80%	5.47%	406.06%	74.52%	-46.99%	92.61%	116.00%	-49.06%	176.75%	-42.39%	-75.48%	71.46%	-27.33%	-27.84%	-28.91%	-8.44%	-25.47%	50.08%	-31.25%	12.08%	41.66%	-28.92%	39.69%	-51.06%	-32.25%	-29.47%	-47.21%	19.15%	-15.25%	-1.15%	80.51%	52.15%	88.46%	71.92%
qoq	15.98%	289.33%	-36.44%	-64.85%	29.94%	-58.91%	266.21%	-50.15%	99.04%	90.11%	14.71%	40.00%	-426.92%	-85.14%	-225.90%	-4.79%	131.75%	-150.40%	NaN%	NaN%	-247.41%	-19.44%	-785.71%	-142.27%	483.10%	-39.23%	-67.98%	-55.75%	496.32%	-198.11%	-74.26%	-4.24%	208.04%	-71.33%	-22.15%	9.41%	195.98%	-26.61%	-66.36%	-54.33%	44.38%	22.65%	30.40%	119.15%	-50.21%	-62.75%	373.81%	145.76%	-88.26%	102.40%	-1.37%	4.62%	-17.90%	-14.22%	-2.06%	3.08%	5.73%	-30.18%	97.23%	-52.79%	72.38%	-11.75%	-1.04%	-7.21%	-39.61%	22.17%	3.02%	-30.54%	36.29%	-13.11%	20.17%	26.84%	14.88%	7.63%	9.62%
net income margin %	12.96%	16.79%	4.78%	8.42%	22.88%	20.80%	55.28%	15.61%	29.17%	16.18%	9.50%	9.11%	6.02%	-1.84%	-14.35%	11.26%	9.49%	4.57%	-9.50%	NaN%	-6.95%	4.96%	6.36%	-1.06%	2.37%	0.44%	0.79%	2.74%	6.00%	1.10%	-1.36%	-5.32%	-5.26%	-1.83%	-7.08%	-9.81%	-8.80%	-3.25%	-4.81%	-15.37%	-27.29%	-21.68%	-20.42%	-19.33%	-7.44%	-14.46%	-40.42%	-8.88%	-3.65%	-34.84%	-17.50%	-18.59%	-17.63%	-22.68%	-28.36%	-30.95%	-30.38%	-30.41%	-60.30%	-34.85%	-75.12%	-47.53%	-59.78%	-66.59%	-73.88%	-131.97%	-138.46%	-157.55%	-238.45%	-205.26%	-321.99%	-297.92%	-359.28%	-359.77%	-394.52%	-575.70%
earnings per share:
basic	1.44	1.24	0.32	0.5	1.133	1.11	2.69	0.74
diluted	1.43	1.24	0.32	0.5	1.1	1.08	2.59	0.73
weighted-average number of common shares outstanding
basic	70,348	70,367	70,389	70,272	70,076	70,123	70,062	69,957	69,751	69,823	69,741	69,583	69,375	69,418	69,356	69,254	67,698	68,869	66,696	66,113	64,735	65,717,820	64,370,791	62,883,672	60,593,846	60,743,211	59,844,991	59,355,031	58,859,574	59,016,863
diluted	71,886	70,661	70,652	74,111	73,890	73,951	73,802	73,741	73,633	73,624	70,142	70,096	69,910	69,418	69,356	69,858	68,579	69,619	66,696	66,113	65,946	66,827,692	65,578,513	62,883,672	62,304,348	62,335,679	61,486,325	61,148,428	61,008,024	61,146,466
other expense				-2,300,000			-1,800,000	-700,000			-200,000		-650,000	-1,800,000						-2,600,000																					-1,250	-10,000			-325,500	-677,000	-890,000	-4,193,000	-2,860,000	-3,972,000	-4,579,000	-4,328,000	-4,039,000	-3,918,000	-3,888,000	-3,839,000	-3,700,000	-3,794,000	-4,508,000	-2,575,000
income tax expense				-12,700,000				-3,400,000				-800,000				-1,500,000					1,400,000	-1,800,000	-3,000,000		-1,814,000	-278,000	482,000	326,000	995,000	194,000	412,000	333,000	-61,000	121,000	101,000	96,000	197,000	66,000	65,000	-64,000	-140,000	-62,000	-37,000	-52,000	-4,000	-21,000	-52,000	-65,000	-63,500	-5,000	-118,000	-131,000	-35,750	-28,000	-69,000	-46,000
net income per share																															-0.03	-0.11									-0.48	-0.33	-0.27	-0.21	-0.1	-0.19	-0.53	-0.11	-0.04	-0.39	-0.2	-0.2	-0.21	-0.26	-0.3	-0.31	-0.3	-0.29	-0.42	-0.22	-0.5	-0.3	-0.36	-0.37	-0.36	-0.88	-0.73	-0.71	-1.02	-0.75	-0.87	-0.73	-0.36	-0.52	-0.99	-23.86
basic									1.48	0.74	0.39	0.34	0.25	-0.08	-0.5	0.4	0.43	0.18	-0.37		-0.26	0.18	0.22	-0.03	0.08	0.01	0.02	0.07	-0.028	0.03
diluted									1.47	0.74	0.39	0.34	0.25	-0.08	-0.5	0.4	0.42	0.18	-0.37		-0.26	0.17	0.22	-0.03	0.08	0.01	0.02	0.07	-0.028	0.03
weighted-average number of common shares outstanding:
basic	70,348	70,367	70,389	70,272	70,076	70,123	70,062	69,957	69,751	69,823	69,741	69,583	69,375	69,418	69,356	69,254	67,698	68,869	66,696	66,113	64,735	65,717,820	64,370,791	62,883,672	60,593,846	60,743,211	59,844,991	59,355,031	58,859,574	59,016,863
diluted	71,886	70,661	70,652	74,111	73,890	73,951	73,802	73,741	73,633	73,624	70,142	70,096	69,910	69,418	69,356	69,858	68,579	69,619	66,696	66,113	65,946	66,827,692	65,578,513	62,883,672	62,304,348	62,335,679	61,486,325	61,148,428	61,008,024	61,146,466
operating expenses:
research and development																									34,703,000	30,779,000	32,264,000	31,954,000	28,514,000	21,762,000	18,418,000	19,912,000	18,782,000	20,141,000	18,029,000	17,500,000	16,034,000	13,734,000	12,953,000	12,989,000	12,897,000	10,035,000	12,069,000	8,207,000	7,286,000	7,158,000	6,677,000	6,779,000	6,424,000	5,771,000	5,174,000	4,396,000	5,847,000	6,559,000	6,521,000	5,432,000	5,804,000	4,638,000	6,832,000	4,589,000	4,438,000	3,698,000	4,583,000	3,847,000	3,351,000	3,404,000	3,272,000	3,204,000	3,535,000	3,263,000	3,382,000	2,923,000	3,170,000	2,231,000	2,520,000	2,470,000
sales and marketing																									48,334,000	47,749,000	47,401,000	41,616,000	39,661,000	34,922,000	35,605,000	32,133,000	35,329,000	28,718,000	29,475,000	28,095,000	25,364,000	22,147,000	22,950,000	24,022,000	24,946,000	24,194,000	21,811,000	17,401,000	17,462,000	14,870,000	14,856,000	13,656,000	12,836,000	15,407,000	13,580,000	13,871,000	12,734,000	13,571,000	13,664,000	12,739,000	12,290,000	12,312,000	9,625,000	9,006,000	8,394,000	8,979,000	9,013,000	8,309,000	8,678,000	9,629,000	10,504,000	8,772,000	9,999,000	10,176,000	10,994,000	8,565,000	5,489,000	4,144,000	3,404,000	3,104,000
general and administrative																									32,941,000	27,548,000	29,150,000	25,861,000	25,904,000	38,420,000	23,724,000	23,770,000	26,165,000	22,718,000	20,493,000	19,111,000	23,674,000	17,342,000	15,842,000	14,739,000	31,518,000	17,156,000	12,856,000	15,829,000	14,180,000	18,890,000	19,512,000	14,259,000	13,552,000	23,530,000	13,901,000	13,094,000	12,824,000	12,731,000	12,665,000	13,020,000	12,498,000	11,379,000	12,996,000	7,211,000	6,288,000	7,230,000	6,190,000	6,959,000	7,267,000	6,246,000	5,838,000	7,491,000	6,850,000	6,308,000	5,395,000	5,197,000	5,077,000	3,388,000	2,798,000	2,660,000
total operating expenses																									115,978,000	106,076,000	108,815,000	99,431,000	94,079,000	95,104,000	77,747,000	75,815,000	80,276,000	71,577,000	67,997,000	64,706,000	65,072,000	53,223,000	51,745,000	51,750,000	69,361,000	51,385,000	46,736,000	41,437,000	38,928,000	40,918,000	41,045,000	34,694,000	32,812,000	44,708,000	32,655,000	31,361,000	31,405,000	32,861,000	32,850,000	31,191,000	30,592,000	28,329,000	29,453,000	20,806,000	23,551,000	19,907,000	19,786,000	19,115,000	19,296,000	19,279,000	19,614,000	19,467,000	28,554,000	19,747,000	19,771,000	16,685,000	13,736,000	10,790,000	8,722,000	8,234,000
interest expense, net of portion capitalized																									-10,973,000	-9,370,000	-7,642,000
weighted-average number of shares used in calculating net income per share:
basic	70,348	70,367	70,389	70,272	70,076	70,123	70,062	69,957	69,751	69,823	69,741	69,583	69,375	69,418	69,356	69,254	67,698	68,869	66,696	66,113	64,735	65,717,820	64,370,791	62,883,672	60,593,846	60,743,211	59,844,991	59,355,031	58,859,574	59,016,863
diluted	71,886	70,661	70,652	74,111	73,890	73,951	73,802	73,741	73,633	73,624	70,142	70,096	69,910	69,418	69,356	69,858	68,579	69,619	66,696	66,113	65,946	66,827,692	65,578,513	62,883,672	62,304,348	62,335,679	61,486,325	61,148,428	61,008,024	61,146,466
interest expense and other income																												2,561,000	4,213,000	5,012,000	5,604,000	6,236,000	3,258,500	4,153,000	4,308,000		-2,823,250	-5,369,000	-2,998,000
net income per share																															-0.03	-0.11									-0.48	-0.33	-0.27	-0.21	-0.1	-0.19	-0.53	-0.11	-0.04	-0.39	-0.2	-0.2	-0.21	-0.26	-0.3	-0.31	-0.3	-0.29	-0.42	-0.22	-0.5	-0.3	-0.36	-0.37	-0.36	-0.88	-0.73	-0.71	-1.02	-0.75	-0.87	-0.73	-0.36	-0.52	-0.99	-23.86
weighted-average number of shares used in calculating net loss per share																															58,833	58,482,786	58,003,434	58,100	57,977	57,694	57,251,377	57,341,063	57,195,963	57,029,575	56,785,646	56,898,281	56,808,489	56,496,648	55,628,542	55,819,242	55,425,949	55,089,028	54,010,887	54,458,364	53,834,707	53,052,400	47,924,324	48,041,392	47,824,190		46,689,880				39,607,899				29,727,106				27,611,003			27,394,322	16,688,418	26,322,763	12,791,190	484,431
loss on extinguishment of long-term debt																																						2,551,000								-4,260,000	-18,943,000
loss from continuing operations before income taxes																																	-6,921,000	-2,106,000	-7,666,000	-9,881,000	-8,956,000	-2,951,000	-4,286,000	-10,625,000
net income from continuing operations																																	-6,860,000	-2,227,000	-7,767,000	-9,977,000	-9,153,000	-3,017,000	-4,351,000	-10,689,000
loss from discontinued operations, net of tax																																					34,000	-64,000		-1,792,000
net loss from continuing operations per share																																	-0.085	-0.04	-0.13	-0.17	-0.08	-0.05
net loss from discontinued operations per share																																					-0.008
income from discontinued operations, net of tax (0 and 22 for the three months ended june 30, 2016 and 2015, respectively and 408 and 50 for the six months ended june 30, 2016 and 2015, respectively.																																							153,000
net loss from continuing operations per share basic and diluted																																							-0.08	-0.19
net income from discontinued operations per share basic and diluted
interest and other expense																																								-2,926,000	-3,147,000	-3,131,000	-3,034,000	-3,152,000	-3,141,000	-7,948,000	-23,779,000	-4,489,000	-4,244,000	-3,999,000	-4,616,000
net loss from discontinued operations per share basic and diluted																																								-0.03
weighted-average number of shares used in calculating basic and diluted net loss per share																																																								47,607,449		47,321,989	46,377,843	45,583,242		40,155,277	38,285,628			28,008,699	27,869,159	27,804,603		27,716,473	27,568,296
net interest expense																																																													-2,848,250	-3,822,000	-3,811,000	-3,125,000	-4,303,000	-11,245,000	-3,794,000
weighted average number of shares used in calculating basic and diluted net loss per share																																																																37,888,258
net interest income																																																																				-2,173,000	-630,500	-918,000	-1,743,000	138,000
gross loss																																																																					1,198,000	-87,000	-2,368,000	-3,327,000	-2,318,000	-3,792,000	-3,687,000	-2,564,000
impairment of assets																																																																										1,027,000
change in value of preferred stock warrant liability																																																																											10,000
accretion of redeemable convertible preferred stock
net loss attributable to common shareholders																																																																									-15,668,000	-13,639,000	-12,672,000	-11,560,000
increase in value of preferred stock warrant liability																																																																												-84,000
pro forma net loss per share basic and diluted																																																																												-0.64
pro forma weighted-average number of shares used in calculating net loss per share																																																																												18,152,203

Balance Sheets:

Quarterly

Annual

Unit: USD	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31

assets
current assets
cash and cash equivalents	716,100,000	757,400,000	1,121,600,000	1,283,100,000	953,400,000	902,600,000	821,000,000	751,200,000	704,200,000	685,400,000	660,100,000	620,700,000	674,700,000	722,000,000	708,600,000	709,600,000	791,600,000	856,600,000	854,600,000	820,700,000	907,200,000	838,100,000	779,100,000	201,400,000	213,700,000	419,882,000	119,867,000	129,254,000	113,906,000	126,563,000	136,246,000	203,146,000	272,577,000	102,233,000	73,488,000	76,038,000	137,174,000	215,402,000	75,661,000	111,635,000	122,672,000	145,467,000	145,137,000	145,608,000	151,193,000	146,372,000	175,545,000	145,614,000	149,727,000	153,905,000	150,944,000	148,065,000	57,293,000	63,443,000	70,144,000	83,006,000	93,955,000	103,812,000	106,746,000	104,488,000	113,274,000	103,918,000	118,071,000	118,338,000	127,996,000	72,694,000	52,362,000	68,164,000	56,663,000	74,134,000	99,108,000	73,035,000
accounts receivable trade	516,900,000				252,500,000				240,200,000				140,900,000								83,800,000
accounts receivable trade, net — related party		155,700,000	138,100,000	119,200,000	113,000,000	113,900,000	99,600,000	86,400,000	119,500,000	79,900,000	82,900,000	57,600,000	64,700,000	48,300,000	52,500,000	35,800,000
inventories	452,600,000	446,300,000	446,900,000	440,800,000	430,400,000	444,900,000	430,900,000	430,600,000	402,600,000	410,800,000	411,300,000	386,100,000	346,800,000	327,600,000	320,400,000	314,800,000	303,200,000	259,000,000	197,800,000	170,100,000	154,300,000	124,900,000	103,700,000	95,700,000	101,000,000	90,207,000	85,109,000	73,822,000	71,414,000	58,050,000	40,808,000	26,334,000	33,793,000	35,054,000	33,956,000	34,333,000	35,514,000	32,663,000	24,486,000	14,024,000	14,043,000	13,019,000	23,435,000	20,065,000	13,099,000	9,662,000	8,765,000	10,449,000	9,464,000	5,395,000	5,979,000	9,199,000	14,867,000	15,089,000	16,426,000	14,703,000	11,838,000	13,123,000	15,957,000	12,199,000	11,430,000	12,909,000	10,231,000	6,600,000	10,086,000	9,175,000	10,409,000	15,147,000	16,870,000	16,467,000	13,336,000	7,506,000	7,990,000	4,572,000	4,129,000	4,256,000
prepaid expenses and other current assets	228,300,000		266,700,000	202,200,000	142,000,000	137,800,000	148,300,000	116,100,000	116,400,000	104,600,000	99,600,000	106,000,000	86,900,000	78,100,000	73,500,000	71,700,000	74,000,000	76,500,000	82,700,000	73,600,000	63,000,000	53,400,000	59,600,000	43,900,000	31,100,000	20,653,000	25,211,000	28,028,000	24,254,000	17,905,000	17,559,000	17,449,000	9,949,000	8,037,000	8,431,000	8,159,000	7,073,000	7,901,000	6,838,000	5,712,000	5,659,000	4,049,000	3,431,000	3,661,000	4,022,000	3,434,000	5,725,000	7,115,000	5,940,000	5,921,000	6,556,000	6,383,000	4,482,000	4,717,000	3,454,000	3,463,000	2,802,000	3,653,000	4,770,000	1,841,000	912,000	1,059,000	1,499,000	2,029,000	1,260,000	1,565,000	2,100,000	3,385,000	3,028,000	3,521,000	2,748,000	2,843,000	1,391,000	1,763,000	1,248,000	1,797,000
total current assets	1,914,000,000	1,859,400,000	2,279,700,000	2,328,400,000	1,891,300,000	1,860,900,000	1,748,800,000	1,618,400,000	1,582,900,000	1,471,100,000	1,421,500,000	1,330,000,000	1,314,000,000	1,329,100,000	1,309,100,000	1,285,400,000	1,329,800,000	1,306,900,000	1,252,900,000	1,191,800,000	1,248,700,000	1,160,400,000	1,085,700,000	541,300,000	591,000,000	793,901,000	498,807,000	496,382,000	461,286,000	445,712,000	421,793,000	451,611,000	537,171,000	366,020,000	338,745,000	337,168,000	369,960,000	361,807,000	181,290,000	171,845,000	190,761,000	194,338,000	203,829,000	205,427,000	208,196,000	206,613,000	231,832,000	199,857,000	198,198,000	199,686,000	197,129,000	194,757,000	109,936,000	113,394,000	115,615,000	127,369,000	131,785,000	137,857,000	147,834,000	133,537,000	142,457,000	133,328,000	145,602,000	142,173,000	154,304,000	99,791,000	80,380,000	99,987,000	88,499,000	105,964,000	124,952,000	90,607,000	108,752,000	113,891,000	127,828,000	27,247,000
property, plant and equipment	819,500,000	724,100,000	720,400,000	718,700,000	723,100,000	702,900,000	677,900,000	667,700,000	664,900,000	649,200,000	601,500,000	596,600,000	599,900,000	553,100,000	535,800,000	538,200,000	536,500,000	515,400,000	505,500,000	497,900,000	478,700,000	449,200,000	423,200,000	412,400,000	399,400,000	355,865,000
other intangible assets	117,100,000	105,000,000	102,300,000	99,800,000	98,500,000	99,600,000	98,500,000	98,500,000	98,700,000	99,500,000	99,500,000	100,200,000	75,500,000	53,700,000	55,100,000	52,800,000	36,600,000	37,200,000	33,400,000	29,700,000	28,700,000	10,400,000	10,900,000	12,400,000	13,200,000	12,834,000	13,040,000	11,484,000	10,383,000	7,791,000	5,747,000	4,570,000	4,351,000	4,369,000	3,386,000	2,208,000	528,000	651,000	773,000	885,000
goodwill	51,600,000	51,600,000	51,700,000	51,500,000	51,500,000	51,700,000	51,700,000	51,700,000	51,700,000	51,700,000	51,700,000	51,700,000	51,700,000	51,600,000	51,800,000	51,800,000	39,800,000	39,800,000	39,900,000	39,800,000	39,800,000	39,700,000	39,600,000	39,600,000	39,800,000	39,713,000	39,739,000	39,694,000	39,646,000	39,774,000	39,731,000	39,773,000	39,840,000	39,854,000	39,759,000	39,697,000	39,677,000	39,730,000	39,763,000	39,761,000	39,747,000	39,823,000	37,536,000	37,536,000	37,536,000	37,536,000	37,536,000	37,536,000	37,536,000	37,536,000	37,536,000	37,536,000	37,536,000	26,647,000	26,647,000	26,647,000	26,647,000	26,164,000	26,727,000
deferred tax assets	82,400,000	100,900,000			141,800,000	144,400,000	141,100,000
other assets	205,800,000	188,300,000	315,100,000	318,900,000	181,500,000	165,900,000	163,600,000	187,700,000	190,000,000	196,200,000	211,600,000	210,600,000	210,000,000	178,700,000	161,900,000	141,000,000	106,100,000	99,600,000	92,000,000	80,900,000	77,000,000	50,400,000	43,800,000	41,700,000	41,100,000	35,071,000	29,435,000	28,658,000	18,266,000	18,057,000	17,961,000	16,663,000	1,969,000	1,614,000	1,559,000	605,000	216,000	98,000	88,000	588,000	104,000	4,384,000	4,687,000	4,986,000	5,291,000	5,493,000	5,919,000	1,652,000	1,825,000	1,721,000	1,886,000	2,056,000	2,202,000	2,333,000	2,503,000	2,647,000	2,727,000	2,791,000	3,104,000	1,133,000	1,254,000	2,379,000	2,637,000	1,730,000	1,862,000	1,806,000	3,244,000	3,442,000	3,166,000	3,288,000	3,377,000	635,000	685,000	754,000	822,000	1,951,000
total assets	3,190,400,000	3,029,300,000	3,469,200,000	3,517,300,000	3,087,700,000	3,025,400,000	2,881,600,000	2,624,000,000	2,588,200,000	2,467,700,000	2,385,800,000	2,289,100,000	2,251,100,000	2,166,200,000	2,113,700,000	2,069,200,000	2,048,800,000	1,998,900,000	1,923,700,000	1,840,100,000	1,872,900,000	1,710,600,000	1,626,700,000	1,108,200,000	1,142,900,000	1,268,390,000	977,723,000	952,612,000	928,744,000	886,306,000	838,856,000	829,763,000	816,744,000	500,348,000	459,327,000	444,957,000	456,647,000	453,197,000	263,045,000	254,774,000	275,126,000	293,120,000	300,393,000	305,716,000	302,156,000	301,197,000	325,328,000	288,528,000	287,955,000	289,496,000	286,152,000	280,899,000	198,059,000	191,642,000	191,940,000	203,942,000	209,583,000	215,780,000	226,190,000	148,926,000	156,233,000	149,854,000	161,990,000	159,037,000	171,648,000	117,128,000	99,313,000	119,852,000	109,229,000	135,332,000	154,573,000	116,467,000	130,741,000	135,605,000	149,140,000	47,682,000
liabilities and stockholders’ equity
current liabilities
accounts payable	75,000,000	48,200,000	96,100,000	57,600,000	19,800,000	40,300,000	76,800,000	75,900,000	19,200,000	77,800,000	107,500,000	85,900,000	30,800,000	62,100,000	57,200,000	52,200,000	37,700,000	58,000,000	49,300,000	59,100,000	54,100,000	57,000,000	35,600,000	36,400,000	54,500,000	21,245,000	24,752,000	26,833,000	25,500,000	26,845,000	25,191,000	33,846,000	24,413,000	28,648,000	12,243,000	6,413,000	13,160,000	18,212,000	21,605,000	13,482,000	18,649,000	15,614,000	17,916,000	14,246,000	14,659,000	17,726,000	18,610,000	20,983,000	19,359,000	15,117,000	11,441,000	8,544,000	9,361,000	16,216,000	13,687,000	16,107,000	11,418,000	8,604,000	9,369,000	6,213,000	4,895,000	5,154,000	9,128,000	3,277,000	5,870,000	5,183,000	5,580,000	5,979,000	7,291,000	5,965,000	5,984,000	7,399,000	4,544,000	4,152,000	5,485,000	4,687,000
accrued expenses and other current liabilities	586,700,000	518,700,000	453,400,000	378,600,000	423,800,000	414,200,000	365,000,000	308,600,000	373,700,000	319,200,000	282,800,000	263,600,000	301,000,000	241,700,000	192,500,000	135,800,000	166,000,000	141,700,000	143,100,000	110,700,000	138,100,000	118,200,000	98,800,000	94,000,000	103,200,000	92,037,000	81,021,000	85,945,000	88,973,000	68,169,000	48,580,000	45,759,000	59,256,000	44,897,000	34,648,000	31,839,000	40,959,000	33,732,000	29,938,000	30,385,000	38,627,000	35,547,000	26,443,000	25,267,000	24,703,000	25,214,000	24,588,000	18,771,000	19,478,000	30,017,000	20,276,000
accrued expenses and other current liabilities — related party		900,000		1,100,000	1,000,000	9,700,000	6,300,000	9,000,000	8,900,000	4,600,000	5,500,000	6,000,000	5,400,000	3,500,000	3,300,000	1,300,000
current portion of long-term debt	18,400,000	79,900,000	460,700,000	83,100,000	83,800,000	42,000,000	37,900,000	38,900,000	49,400,000	49,800,000	29,200,000	27,800,000	27,500,000	26,900,000	26,300,000	25,700,000	25,100,000	28,900,000	20,900,000	15,700,000	15,600,000																										23,874,000					14,733,000	14,429,000	14,134,000	13,849,000																	10,670,000	10,671,000	10,671,000	7,943,000	29,225,000
total current liabilities	680,100,000	647,700,000	1,010,100,000	520,400,000	528,400,000	506,200,000	486,000,000	432,400,000	451,200,000	451,400,000	425,000,000	383,300,000	364,700,000	334,200,000	279,300,000	215,000,000	228,800,000	228,600,000	213,300,000	185,500,000	207,800,000	175,200,000	134,400,000	130,400,000	157,700,000	113,282,000	105,773,000	113,973,000	115,657,000	97,224,000	76,109,000	82,414,000	86,025,000	74,940,000	48,018,000	39,379,000	55,697,000	54,252,000	55,181,000	49,775,000	65,156,000	59,437,000	52,682,000	47,376,000	44,296,000	47,764,000	71,199,000	43,118,000	42,374,000	48,294,000	33,853,000	42,980,000	48,286,000	49,342,000	43,140,000	32,580,000	27,995,000	24,761,000	26,611,000	16,797,000	18,950,000	20,442,000	23,760,000	17,932,000	19,813,000	18,217,000	16,783,000	19,790,000	16,968,000	15,823,000	15,534,000	25,944,000	21,029,000	19,306,000	17,045,000	40,931,000
long-term debt	930,800,000	934,900,000	939,000,000	1,612,300,000	1,296,100,000	1,356,300,000	1,359,900,000	1,362,600,000	1,366,400,000	1,370,600,000	1,368,600,000	1,368,800,000	1,374,300,000	1,379,800,000	1,385,200,000	1,390,500,000	1,248,800,000	1,257,000,000	1,235,200,000	1,051,600,000	1,043,700,000								591,978,000				566,173,000	344,953,000	340,836,000	336,762,000	332,768,000	328,962,000	175,690,000	173,681,000	171,698,000	173,870,000	172,220,000	170,595,000	168,994,000	167,418,000	165,870,000	116,277,000	113,651,000	111,117,000	108,670,000	106,186,000	103,730,000	101,517,000	99,382,000	110,844,000	108,540,000	106,319,000	104,177,000	70,857,000	69,433,000	94,179,000	92,292,000	98,217,000	96,979,000	95,902,000	83,079,000	81,446,000	85,000,000	85,000,000	85,000,000	13,338,000	16,006,000	18,673,000	21,341,000
other liabilities	64,400,000	62,600,000	57,100,000	53,900,000	51,600,000	44,900,000	37,300,000	38,300,000	37,900,000	38,200,000	38,300,000	34,200,000	35,700,000	24,200,000	26,800,000	17,000,000	14,900,000	15,400,000	16,100,000	17,700,000	17,800,000	18,900,000	18,800,000	19,800,000	21,400,000	18,769,000	14,819,000
total liabilities	1,675,200,000	1,645,100,000	2,006,300,000	2,186,600,000	1,876,100,000	1,907,400,000	1,883,200,000	1,833,300,000	1,855,500,000	1,860,200,000	1,831,900,000	1,786,300,000	1,774,700,000	1,738,200,000	1,691,300,000	1,622,500,000	1,492,500,000	1,501,000,000	1,464,600,000	1,254,800,000	1,269,300,000	1,115,600,000	1,063,400,000	1,049,200,000	1,067,000,000	1,117,822,000	727,943,000	728,982,000	716,645,000	688,377,000	659,708,000	659,195,000	658,228,000	426,094,000	394,602,000	381,372,000	393,497,000	388,102,000	235,601,000	228,378,000	241,075,000	237,987,000	230,138,000	224,974,000	218,327,000	220,857,000	242,483,000	166,036,000	163,358,000	168,070,000	147,817,000	151,352,000	153,883,000	152,529,000	144,190,000	145,064,000	138,187,000	132,340,000	132,091,000	89,146,000	90,002,000	116,349,000	118,009,000	118,113,000	118,791,000	116,825,000	102,784,000	104,395,000	104,955,000	103,684,000	103,282,000	42,828,000	38,466,000	39,307,000	39,620,000	41,248,000
commitments and contingencies
stockholders’ equity
preferred stock, .001 par value...
common stock, .001 par value...	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000		100,000	100,000	100,000		100,000	100,000	100,000		62,000	60,000
additional paid-in capital	1,274,900,000	1,245,800,000	1,379,400,000	1,260,900,000	1,184,400,000	1,158,600,000	1,140,600,000	1,117,600,000	1,102,600,000	1,081,100,000	1,070,700,000	1,047,300,000	1,040,600,000	1,022,400,000	1,011,200,000	995,500,000	1,207,900,000	1,179,900,000	1,149,600,000	1,248,300,000	1,264,300,000	1,244,700,000	1,227,600,000	737,900,000	749,000,000	832,140,000	930,383,000	905,891,000	898,559,000	893,829,000	876,641,000	865,520,000	866,206,000	774,714,000	763,364,000	754,585,000	744,243,000	736,730,000	695,854,000	690,619,000	686,193,000	679,761,000	675,489,000	670,544,000	661,798,000	652,909,000	639,609,000	655,106,000	651,067,000	645,396,000	641,016,000	621,710,000	525,679,000	521,761,000	517,981,000	514,633,000	512,371,000	510,077,000	507,174,000	453,435,000	450,039,000	396,459,000	394,835,000	384,631,000	382,709,000	315,230,000	286,734,000	285,423,000	252,615,000	251,706,000	250,598,000	249,064,000	247,835,000	236,182,000	235,765,000	524,000
accumulated earnings	287,400,000	185,800,000	98,200,000	75,700,000	40,300,000
accumulated other comprehensive income	12,500,000	12,200,000	15,400,000		-13,200,000	19,700,000	-4,400,000	-500,000	8,000,000	7,600,000	16,300,000	15,900,000	20,000,000	6,800,000	7,200,000	12,200,000	-2,200,000	-3,400,000	700,000	3,200,000	5,500,000
treasury stock	-60,400,000	-60,500,000	-31,000,000	-200,000
deferred compensation	800,000	900,000	900,000	200,000
total stockholders’ equity	1,515,200,000	1,384,100,000	1,462,900,000	1,330,700,000	1,211,600,000	1,118,000,000	998,400,000	790,700,000	732,700,000	607,500,000	553,900,000	502,800,000	476,400,000	428,000,000	422,400,000	446,700,000	556,300,000	497,900,000	459,100,000	585,300,000	603,600,000	595,000,000	563,300,000	59,000,000	75,900,000	150,568,000	249,780,000	223,630,000	212,099,000	197,929,000	179,148,000	170,568,000	158,516,000	74,254,000	64,725,000	63,585,000	63,150,000	65,095,000	27,444,000	26,396,000	34,051,000	55,133,000	70,255,000	80,742,000	83,829,000	80,340,000	77,884,000	122,492,000	124,597,000	121,426,000	138,335,000	129,547,000	44,176,000	39,113,000	47,750,000	58,878,000	71,396,000	83,440,000	94,099,000	59,780,000	66,231,000	33,505,000	43,981,000		52,857,000	303,000	-3,471,000	15,457,000	4,274,000	31,648,000	51,291,000	73,639,000	92,275,000	96,298,000	109,520,000
total liabilities and stockholders’ equity	3,190,400,000	3,029,300,000	3,469,200,000	3,517,300,000	3,087,700,000	3,025,400,000	2,881,600,000	2,624,000,000	2,588,200,000	2,467,700,000	2,385,800,000	2,289,100,000	2,251,100,000	2,166,200,000	2,113,700,000	2,069,200,000	2,048,800,000	1,998,900,000	1,923,700,000	1,840,100,000	1,872,900,000	1,710,600,000	1,626,700,000	1,108,200,000	1,142,900,000	1,268,390,000	977,723,000	952,612,000	928,744,000	886,306,000	838,856,000	829,763,000	816,744,000	500,348,000	459,327,000	444,957,000	456,647,000	453,197,000	263,045,000	254,774,000	275,126,000	293,120,000	300,393,000	305,716,000	302,156,000	301,197,000		288,528,000	287,955,000	289,496,000	286,152,000	280,899,000	198,059,000	191,642,000	191,940,000	203,942,000	209,583,000	215,780,000	226,190,000	148,926,000	156,233,000	149,854,000	161,990,000		171,648,000	117,128,000	99,313,000	119,852,000	109,229,000	135,332,000	154,573,000	116,467,000	130,741,000	135,605,000	149,140,000
accounts receivable trade, net of allowance for credit losses of 1.6 and 1.4		306,500,000	306,400,000
prepaid expenses		72,600,000
other current assets		120,800,000
accounts receivable trade, net of allowance for credit losses				283,100,000
accumulated other comprehensive loss				-6,000,000																		-600,000	-3,600,000	-3,800,000	-1,200,000	-4,652,000	-2,829,000	-3,085,000	-2,905,000	-2,452,000	-2,386,000	-1,536,000	-493,000	-123,000	-529,000	-657,000	-726,000	-387,000	-243,000	-254,000	-654,000	-467,000
accounts receivable trade, less allowance for credit losses of 2.8 and 2.5						261,700,000	249,000,000
accumulated deficit						-60,400,000	-137,900,000	-326,500,000	-378,000,000	-481,300,000	-533,200,000	-560,500,000	-584,300,000	-601,300,000	-596,100,000	-561,100,000	-649,500,000	-678,700,000	-691,300,000	-666,300,000	-666,300,000	-649,200,000	-660,800,000	-675,200,000	-672,000,000	-676,982,000	-677,834,000	-679,236,000	-683,614,000	-693,507,000	-695,166,000	-693,475,000	-707,255,000	-700,395,000	-698,168,000	-690,401,000	-680,424,000	-671,305,000	-668,224,000	-664,026,000	-651,545,000	-624,218,000	-605,291,000	-589,859,000	-578,025,000	-572,625,000	-561,780,000	-532,669,000	-526,525,000	-524,025,000	-502,735,000	-492,216,000	-481,551,000	-482,696,000	-470,279,000	-455,803,000	-441,023,000	-426,684,000	-413,122,000	-393,701,000	-383,853,000	-362,995,000	-350,895,000	-343,746,000	-329,891,000	-314,959,000	-290,234,000	-269,995,000	-248,370,000	-220,087,000	-199,335,000	-175,453,000	-155,579,000	-139,911,000	-126,272,000	-113,600,000
accounts receivable trade, less allowance for credit losses of 3.5 and 2.5								234,100,000
accounts receivable trade, less allowance for credit losses of 2.5 and 2.5										190,400,000
accounts receivable trade, less allowance for credit losses of 3.1 and 2.5											167,600,000	159,600,000
accounts receivable trade, less allowance for credit losses of 2.9 and 2.7														153,100,000
accounts receivable trade, less allowance for credit losses of 3.1 and 2.7															154,100,000
accounts receivable trade, less allowance for credit losses of 2.8 and 2.7																153,500,000
short-term investments																		500,000	17,500,000	29,500,000	40,400,000	58,600,000	65,300,000	120,200,000	162,400,000	185,622,000	189,881,000	187,120,000	175,040,000	163,281,000	163,546,000	148,853,000	167,479,000	173,523,000	185,117,000	177,990,000	161,396,000	67,293,000	35,605,000
accounts receivable																	161,000,000											68,655,000	63,294,000	69,950,000	49,676,000	50,383,000	53,373,000	47,173,000	37,753,000	40,648,000	28,803,000	38,548,000	38,700,000	40,474,000	48,387,000	31,803,000	31,826,000	36,093,000	39,882,000	47,145,000	41,797,000	36,679,000	33,067,000	34,465,000	33,650,000	31,110,000	33,294,000	30,145,000	25,591,000	26,197,000	23,190,000	17,269,000	20,361,000	15,009,000	16,841,000	15,442,000	15,801,000	15,206,000	14,962,000	16,357,000	15,509,000	13,291,000	11,938,000	11,842,000	9,760,000	7,223,000	4,783,000	3,343,000	2,633,000	2,118,000
commitment and contingencies
preferred stock, .001 par value:
authorized: 5,000,000 shares at december 31, 2021 and 2020issued and outstanding: zero shares at december 31, 2021 and 2020
common stock
authorized: 100,000,000 shares at december 31, 2021 and 2020issued and outstanding: 69,178,691 and 66,017,444 shares at december 31, 2021 and 2020																	100,000
accounts receivable trade, less allowance for credit losses of 3.0 and 2.9																		114,300,000
accounts receivable trade, less allowance for credit losses of 3.7 and 2.9																			100,300,000
accounts receivable trade, less allowance for credit losses of 4.0 and 2.9,																				97,900,000
long-term investments																						500,000	23,500,000	60,800,000	58,400,000	31,006,000	62,677,000	76,789,000	140,784,000	145,539,000	156,060,000	164,117,000	125,549,000
authorized: 5,000,000 shares at december 31, 2020 and 2019.issued and outstanding: zero shares at december 31, 2020 and 2019.
authorized: 100,000,000 shares at december 31, 2020 and 2019.issued and outstanding: 66,017 and 62,685 shares at december 31, 2020 and 2019																					100,000
accounts receivable trade, less allowance for credit losses of 3.6 and 3.8																						85,400,000
convertible debt																						921,500,000	910,200,000	899,000,000	887,900,000	985,771,000	607,351,000	599,601,000		584,485,000	577,119,000	569,877,000
accounts receivable trade, less allowance for credit losses of 4.6 and 3.8																							78,000,000
accounts receivable trade, less allowance for credit losses of 4.1 and 3.8																								80,100,000
liabilities and shareholders’ equity
accounts receivable trade, less allowance for doubtful accounts of 3.8 and 3.6																									69,300,000
unbilled receivable																									13,500,000	12,485,000	11,781,000	9,503,000	13,378,000	9,963,000	13,958,000	5,446,000
authorized: 5,000,000 shares at december 31, 2019 and 2018. issued and outstanding: zero shares at december 31, 2019 and 2018.
authorized: 100,000,000 shares at december 31, 2019 and 2018. issued and outstanding: 62,685,492 and 59,188,758 shares at december 31, 2019 and 2018, respectively.																									100,000
accounts receivable trade, less allowance for doubtful accounts of 4,174 and 3,610																										65,052,000
accounts receivable trade, less allowance for doubtful accounts of 4,098 and 3,610																											66,958,000
property and equipment																											334,025,000	299,605,000	258,379,000	229,433,000	197,564,000	153,029,000	107,864,000	88,491,000	75,878,000	65,279,000	46,266,000	50,911,000	41,131,000	41,695,000	41,793,000	41,536,000	42,040,000	44,612,000	37,069,000	36,582,000	34,159,000	32,556,000	32,356,000	31,399,000	29,334,000	24,982,000	25,422,000	24,910,000	21,422,000	19,947,000	19,422,000	18,295,000	16,125,000	14,256,000	12,522,000	14,147,000	13,751,000	15,134,000	15,482,000	15,531,000	15,689,000	16,423,000	17,564,000	26,080,000	26,244,000	25,225,000	21,304,000	20,960,000	20,490,000	18,484,000
deferred revenue																												1,195,000	1,184,000	2,210,000	2,338,000	2,809,000	2,356,000	1,395,000	1,127,000	1,127,000	1,309,000	1,247,000	1,323,000	1,461,000	2,361,000	2,256,000	2,088,000	1,867,000	1,554,000	834,000	1,255,000	612,000	900,000	567,000	900,000	1,661,000	5,445,000	1,138,000	1,148,000	2,631,000	2,582,000	2,193,000	3,725,000	1,842,000	4,247,000	3,826,000	4,818,000	4,527,000	3,970,000	3,411,000	3,050,000	2,484,000	2,377,000	2,271,000	1,681,000	1,337,000	1,350,000	711,000	763,000	679,000
other long-term liabilities																												15,408,000	9,010,000	6,668,000	6,480,000	6,904,000	6,030,000	6,201,000	5,748,000	5,231,000	5,032,000	4,888,000	4,730,000	4,922,000	3,952,000	3,619,000	2,921,000	3,038,000	2,774,000	2,580,000	1,521,000	1,984,000	1,943,000	2,567,000	2,246,000	2,186,000	1,867,000	1,670,000	1,668,000	1,640,000	1,652,000	1,260,000	1,303,000	1,492,000	1,619,000	1,728,000	1,957,000	1,964,000	1,999,000	2,706,000	2,922,000	3,159,000	2,987,000	2,861,000	2,748,000	3,546,000	1,431,000	1,328,000	1,234,000	317,000
authorized: 5,000,000 shares at march 31, 2019 and december 31, 2018. issued and outstanding: zero shares at march 31, 2019 and december 31, 2018.
authorized: 100,000,000 at march 31, 2019 and december 31, 2018.issued and outstanding: 59,638,439 and 59,188,758 at march 31, 2019 and december 31, 2018, respectively.																												60,000
authorized: 5,000,000 shares at december 31, 2018 and 2017. issued and outstanding: zero shares at december 31, 2018 and 2017
authorized: 100,000,000 shares at december 31, 2018 and 2017. issued and outstanding: 59,188,758 and 58,319,348 shares at december 31, 2018 and 2017, respectively																													59,000
authorized: 5,000,000 shares at september 30, 2018 and december 31, 2017. issued and outstanding: zero shares at september 30, 2018 and december 31, 2017.
authorized: 100,000,000 at september 30, 2018 and december 31, 2017.issued and outstanding: 59,068,586 and 58,319,348 at september 30, 2018 and december 31, 2017, respectively.																														59,000
authorized: 5,000,000 shares at june 30, 2018 and december 31, 2017. issued and outstanding: zero shares at june 30, 2018 and december 31, 2017.
authorized: 100,000,000 at june 30, 2018 and december 31, 2017.issued and outstanding: 58,975,395 and 58,319,348 at june 30, 2018 and december 31, 2017, respectively.																															59,000
authorized: 5,000,000 shares at march 31, 2018 and december 31, 2017. issued and outstanding: zero shares at march 31, 2018 and december 31, 2017.
authorized: 100,000,000 at march 31, 2018 and december 31, 2017.issued and outstanding: 58,723,242 and 58,319,348 at march 31, 2018 and december 31, 2017, respectively.																																59,000
authorized: 5,000,000 shares at december 31, 2017 and 2016. issued and outstanding: zero shares at december 31, 2017 and 2016
authorized: 100,000,000 shares at december 31, 2017 and 2016. issued and outstanding: 58,319,348 and 57,457,967 shares at december 31, 2017 and 2016, respectively																																	58,000
authorized: 5,000,000 shares at september 30, 2017 and december 31, 2016. issued and outstanding: zero shares at september 30, 2017 and december 31, 2016.
authorized: 100,000,000 shares at september 30, 2017 and december 31, 2016. issued and outstanding: 58,156,128 and 57,457,967 shares at september 30, 2017 and december 31, 2016, respectively.																																		58,000
authorized: 5,000,000 shares at june 30, 2017 and december 31, 2016. issued and outstanding: zero shares at june 30, 2017 and december 31, 2016.
authorized: 100,000,000 shares at june 30, 2017 and december 31, 2016. issued and outstanding: 58,044,088 and 57,457,967 shares at june 30, 2017 and december 31, 2016, respectively.																																			58,000
authorized: 5,000,000 shares at march 31, 2017 and december 31, 2016. issued and outstanding: zero shares at march 31, 2017 and december 31, 2016.
authorized: 100,000,000 shares at march 31, 2017 and december 31, 2016. issued and outstanding: 57,912,745 and 57,457,967 shares at march 31, 2017 and december 31, 2016, respectively.																																				58,000
current assets from discontinued operations
long-term assets from discontinued operations
current portion of capital lease obligations																																					269,000	1,061,000	2,315,000	4,447,000	5,519,000	6,020,000	6,235,000	5,996,000	3,380,000	3,990,000	2,872,000	2,752,000	2,637,000	2,593,000
current liabilities from discontinued operations
capital lease obligations																																									269,000	1,061,000	2,315,000	3,965,000	2,263,000	3,095,000	3,893,000	4,657,000	5,390,000	6,092,000
authorized: 5,000,000 shares at december 31, 2016 and 2015. issued and outstanding: zero shares at december 31, 2016 and 2015
authorized: 100,000,000 shares at december 31, 2016 and 2015. issued and outstanding: 57,457,967 and 56,954,830 shares at december 31, 2016 and 2015, respectively																																					57,000
current assets of discontinued operations
long-term assets of discontinued operations
current liabilities of discontinued operations
authorized: 5,000,000 shares at september 30, 2016 and december 31, 2015. issued and outstanding: zero shares at september 30, 2016 and december 31, 2015.
authorized: 100,000,000 shares at september 30, 2016 and december 31, 2015. issued and outstanding: 57,418,432 and 56,954,830 shares at september 30, 2016 and december 31, 2015, respectively.																																						57,000
authorized: 5,000,000 shares at june 30, 2016 and december 31, 2015. issued and outstanding: zero shares at june 30, 2016 and december 31, 2015.
authorized: 100,000,000 shares at june 30, 2016 and december 31, 2015. issued and outstanding: 57,240,894 and 56,954,830 shares at june 30, 2016 and december 31, 2015, respectively.																																							57,000
authorized: 5,000,000 shares at march 31, 2016 and december 31, 2015. issued and outstanding: zero shares at march 31, 2016 and december 31, 2015.
authorized: 100,000,000 shares at march 31, 2016 and december 31, 2015. issued and outstanding: 57,112,482 and 56,954,830 shares at march 31, 2016 and december 31, 2015, respectively.																																								57,000
intangible assets																																									2,721,000	13,039,000	12,301,000	13,155,000	14,064,000	14,973,000	15,882,000	16,927,000	18,040,000	19,154,000	20,267,000	21,568,000	22,963,000	24,358,000	25,753,000	27,332,000	29,002,000	30,673,000	32,400,000
authorized: 5,000,000 shares at december 31, 2015 and 2014. issued and outstanding: zero shares at december 31, 2015 and 2014.
authorized: 100,000,000 shares at december 31, 2015 and 2014. issued and outstanding: 56,954,830 and 56,299,022 shares at december 31, 2015 and 2014, respectively.																																									57,000
authorized: 5,000,000 shares at september 30, 2015 and december 31, 2014. issued and outstanding: zero shares at september 30, 2015 and december 31, 2014.
authorized: 100,000,000 shares at september 30, 2015 and december 31, 2014. issued and outstanding: 56,914,557 and 56,299,022 shares at september 30, 2015 and december 31, 2014, respectively.																																										57,000
authorized: 5,000,000 shares at june 30, 2015 and december 31, 2014. issued and outstanding: zero shares at june 30, 2015 and december 31, 2014.
authorized: 100,000,000 shares at june 30, 2015 and december 31, 2014. issued and outstanding: 56,876,012 and 56,299,022 shares at june 30, 2015 and december 31, 2014, respectively.																																											57,000
authorized: 5,000,000 shares at march 31, 2015 and december 31, 2014. issued and outstanding: zero shares at march 31, 2015 and december 31, 2014.
authorized: 100,000,000 shares at march 31, 2015 and december 31, 2014. issued and outstanding: 56,704,347 and 56,299,022 shares at march 31, 2015 and december 31, 2014, respectively.																																												57,000
authorized: 5,000,000 shares at december 31, 2014 and 2013.
issued and outstanding: zero shares at december 31, 2014 and 2013.
authorized: 100,000,000 shares at december 31, 2014 and 2013.
issued and outstanding: 56,299,022 and 54,870,424 shares at december 31, 2014 and 2013, respectively.																																													56,000
authorized: 5,000,000 shares at september 30, 2014 and december 31, 2013. issued and outstanding: zero shares at september 30, 2014 and december 31, 2013.
authorized: 100,000,000 shares at september 30, 2014 and december 31, 2013. issued and outstanding: 56,040,361 and 54,870,424 shares at september 30, 2014 and december 31, 2013, respectively.																																														56,000
redeemable convertible debt																																															4,961,000
authorized: 5,000,000 shares at june 30, 2014 and december 31, 2013. issued and outstanding: zero shares at june 30, 2014 and december 31, 2013.
authorized: 100,000,000 shares at june 30, 2014 and december 31, 2013. issued and outstanding: 55,495,352 and 54,870,424 shares at june 30, 2014 and december 31, 2013, respectively.																																															55,000
total liabilities, redeemable convertible debt and stockholders’ equity																																															325,328,000
authorized: 5,000,000 shares at march 31, 2014 and december 31, 2013. issued and outstanding: zero shares at march 31, 2014 and december 31, 2013.
authorized: 100,000,000 shares at march 31, 2014 and december 31, 2013. issued and outstanding: 55,261,626 and 54,870,424 shares at march 31, 2014 and december 31, 2013, respectively.																																																55,000
authorized: 5,000,000 shares at december 31, 2013 and 2012.
issued and outstanding: zero shares at december 31, 2013 and 2012.
authorized: 100,000,000 shares at december 31, 2013 and 2012.
issued and outstanding: 54,870,424 and 48,359,063 shares at december 31, 2013 and 2012, respectively.																																																	55,000
authorized: 5,000,000 shares at september 30, 2013 and december 31, 2012 issued and outstanding: zero shares at september 30, 2013 and december 31, 2012
authorized: 100,000,000 shares at september 30, 2013 and december 31, 2012 issued and outstanding: 54,521,310 and 48,359,063 shares at september 30, 2013 and december 31, 2012, respectively																																																		55,000
current portion of capital lease obligation																																																			1,236,000
capital lease obligation																																																			3,048,000
authorized: 5,000,000 shares at june 30, 2013 and december 31, 2012 issued and outstanding: zero shares at june 30, 2013 and december 31, 2012
authorized: 100,000,000 shares at june 30, 2013 and december 31, 2012 issued and outstanding: 54,329,612 and 48,359,063 shares at june 30, 2013 and december 31, 2012, respectively																																																			54,000
accrued expenses																																																				18,022,000	19,026,000	17,816,000	13,535,000	12,916,000	13,064,000	12,762,000	12,276,000	8,742,000	9,808,000	11,462,000	9,814,000	10,128,000	9,973,000	9,623,000	8,153,000	11,327,000	7,300,000	7,587,000	7,869,000	6,538,000	4,464,000	3,772,000	2,854,000	4,325,000
other current liabilities																																																				20,000	25,000	38,000	921,000	926,000	931,000	1,202,000	1,241,000
authorized: 5,000,000 shares at march 31, 2013 and december 31, 2012 issued and outstanding: zero shares at march 31, 2013 and december 31, 2012
authorized: 100,000,000 shares at march 31, 2013 and december 31, 2012 issued and outstanding: 53,301,450 and 48,359,063 shares at march 31, 2013 and december 31, 2012, respectively																																																				53,000
authorized: 5,000,000 shares at december 31, 2012 and 2011.
issued and outstanding: zero shares at december 31, 2012 and 2011.
authorized: 100,000,000 shares at december 31, 2012 and 2011.
issued and outstanding: 48,359,063 and 47,504,131 shares at december 31, 2012 and 2011.																																																					48,000
authorized: 5,000,000 shares at september 30, 2012 and december 31, 2011. issued and outstanding: zero shares at september 30, 2012 and december 31, 2011
authorized: 100,000,000 shares at september 30, 2012 and december 31, 2011. issued and outstanding: 48,114,876 and 47,504,131 shares at september 30, 2012 and december 31, 2011, respectively																																																						48,000
authorized: 5,000,000 shares at june 30, 2012 and december 31, 2011. issued and outstanding: zero shares at june 30, 2012 and december 31, 2011
authorized: 100,000,000 shares at june 30, 2012 and december 31, 2011. issued and outstanding: 47,915,851 and 47,504,131 shares at june 30, 2012 and december 31, 2011, respectively																																																							48,000
authorized: 5,000,000 shares at march 31, 2012 and december 31, 2011. issued and outstanding: zero shares at march 31, 2012 and december 31, 2011
authorized: 100,000,000 shares at march 31, 2012 and december 31, 2011. issued and outstanding: 47,712,076 and 47,504,131 shares at march 31, 2012 and december 31, 2011, respectively																																																								48,000
authorized: 5,000,000 shares at december 31, 2011 and 2010 issued: zero shares at december 31, 2011 and 2010
authorized: 100,000,000 shares at december 31, 2011 and 2010 issued: 47,504,131 and 45,440,839 shares at december 31, 2011 and 2010, respectively																																																									48,000
authorized: 5,000,000 shares at september 30, 2011 and december 31, 2010. issued and outstanding: zero shares at september 30, 2011 and december 31, 2010, respectively
authorized: 100,000,000 shares at september 30, 2011 and december 31, 2010. issued and outstanding: 47,386,448 and 45,440,839 shares at september 30, 2011 and december 31, 2010, respectively																																																										47,000
authorized: 5,000,000 shares at june 30, 2011 and december 31, 2010. issued and outstanding: zero shares at june 30, 2011 and december 31, 2010, respectively
authorized: 100,000,000 shares at june 30, 2011 and december 31, 2010. issued and outstanding: 47,254,163 and 45,440,839 shares at june 30, 2011 and december 31, 2010, respectively																																																											47,000
authorized: 5,000,000 shares at march 31, 2011 and december 31, 2010. issued and outstanding: zero shares at march 31, 2011 and december 31, 2010
authorized: 100,000,000 shares at march 31, 2011 and december 31, 2010. issued and outstanding: 45,829,569 and 45,440,839 shares at march 31, 2011 and december 31, 2010, respectively																																																												46,000
authorized: 5,000,000 shares at december 31, 2010 and 2009.
issued: zero shares at december 31, 2010 and 2009
authorized: 100,000,000 shares at december 31, 2010 and 2009.
issued: 45,440,839 and 37,755,254 shares at december 31, 2010 and 2009, respectively																																																													45,000
authorized: 5,000,000 shares at september 30, 2010 and december 31, 2009. issued and outstanding: zero shares at september 30, 2010 and december 31, 2009, respectively
authorized: 100,000,000 shares at september 30, 2010 and december 31, 2009. issued and outstanding: 40,171,434 and 37,755,254 shares at september 30, 2010 and december 31, 2009, respectively																																																														41,000
authorized: 5,000,000 shares at june 30, 2010 and december 31, 2009. issued and outstanding: zero shares at june 30, 2010 and december 31, 2009, respectively
authorized: 100,000,000 shares at june 30, 2010 and december 31, 2009. issued and outstanding: 40,121,272 and 37,755,254 shares at june 30, 2010 and december 31, 2009, respectively																																																															41,000
liabilities and stockholders' equity
stockholders' equity
authorized: 5,000,000 shares at march 31, 2010 and december 31, 2009. issued and outstanding: zero shares at march 31, 2010 and december 31, 2009
authorized: 100,000,000 shares at march 31, 2010 and december 31, 2009. issued and outstanding: 37,939,752 and 37,755,254 shares at march 31, 2010 and december 31, 2009, respectively																																																																39,000
total stockholders' equity																																																																40,924,000
total liabilities and stockholders' equity																																																																159,037,000
authorized: 5,000,000 shares at december 31, 2009 and 2008.
issued: zero shares at december 31, 2009 and 2008
authorized: 100,000,000 shares at december 31, 2009 and 2008
issued: 37,755,254 and 27,778,921 shares at december 31, 2009 and 2008, respectively																																																																	39,000
authorized: 5,000,000 shares at september 30, 2009 and december 31, 2008.
issued and outstanding: zero shares at september 30, 2009 and december 31, 2008, respectively
authorized: 100,000,000 shares at september 30, 2009 and december 31, 2008
issued and outstanding: 30,789,239 and 27,778,921 shares at september 30, 2009 and december 31, 2008, respectively																																																																		32,000
authorized: 5,000,000 shares at june 30, 2009 and december 31, 2008. issued and outstanding: zero shares at june 30, 2009 and december 31, 2008, respectively
authorized: 100,000,000 shares at june 30, 2009 and december 31, 2008
issued and outstanding: 27,909,516 and 27,778,921 shares at june 30, 2009 and december 31, 2008, respectively																																																																			29,000
authorized: 5,000,000 shares at march 31, 2009 and december 31, 2008.
issued and outstanding: zero shares at march 31, 2009 and december 31, 2008
authorized: 100,000,000 shares at march 31, 2009 and december 31, 2008.
issued and outstanding: 27,839,115 and 27,778,921 shares at march 31, 2009 and december 31, 2008, respectively																																																																				29,000
authorized: 5,000,000 shares at december 31, 2008 and 2007
issued: zero shares at december 31, 2008 and 2007
authorized: 100,000,000 shares at december 31, 2008 and 2007
issued: 27,778,921 and 27,223,820 shares at december 31, 2008 and 2007, respectively																																																																					29,000
subscription receivable																																																																									-9,000
authorized: 5,000,000 shares at september 30, 2008 and december 31, 2007. issued and outstanding: zero shares at september 30, 2008 and december 31, 2007
authorized: 100,000,000 shares at september 30, 2008 and december 31, 2007. issued and outstanding: 27,748,162 and 27,223,820 shares at september 30, 2008 and december 31, 2007, respectively																																																																						29,000
authorized: 5,000,000 shares at june 30, 2008 and december 31, 2007. issued and outstanding: zero shares at june 30, 2008 and december 31, 2007, respectively
authorized: 100,000,000 shares at june 30, 2008 and december 31, 2007 issued and outstanding: 27,704,110 and 27,223,820 shares at june 30, 2008 and december 31, 2007, respectively																																																																							28,000
preferred stock warrant liability																																																																												2,015,000
authorized: 5,000,000 shares at march 31, 2008 and december 31, 2007.
issued and outstanding: zero shares at march 31, 2008 and december 31, 2007
authorized: 100,000,000 shares at march 31, 2008 and december 31, 2007
issued and outstanding: 27,535,871 and 27,223,820 shares at march 31, 2008 and december 31, 2007, respectively																																																																								28,000
currents assets
cash																																																																									94,588,000	104,213,000	119,818,000	19,076,000
liabilities, redeemable convertible preferred stock and stockholders’ equity
currents liabilities
redeemable convertible preferred stock
authorized: zero and 46,408,050 shares at december 31, 2007 and 2006, respectively
issued and outstanding series a: zero and 1,000,000 shares stated at liquidation and redemption value at december 31, 2007 and 2006, respectively
issued and outstanding series b: zero and 5,945,946 shares stated at liquidation and redemption value at december 31, 2007 and 2006, respectively
issued and outstanding series c: zero and 10,476,191 shares stated at liquidation and redemption value at december 31, 2007 and 2006, respectively
issued and outstanding series d: zero and 14,669,421 shares stated at liquidation and redemption value at december 31, 2007 and 2006, respectively
issued and outstanding series e: zero and 13,738,661 shares stated at liquidation and redemption value at december 31, 2007 and 2006, respectively
preferred stock, .001 par value: authorized 5,000,000 and zero shares at december 31, 2007 and 2006, respectively. issued and outstanding zero shares at december 31, 2007 and 2006, respectively
authorized: 100,000,000 and 65,000,000 shares authorized at december 31, 2007 and 2006, respectively
issued: 27,223,820 and 457,076 shares at december 31, 2007 and 2006, respectively																																																																									28,000
authorized: zero and 46,408,050 shares at september 30, 2007 and december 31, 2006, respectively
issued and outstanding series a: zero and 1,000,000 shares stated at liquidation and redemption value at september 30, 2007 and december 31, 2006, respectively
issued and outstanding series b: zero and 5,945,946 shares stated at liquidation and redemption value at september 30, 2007 and december 31, 2006, respectively
issued and outstanding series c: zero and 10,476,191 shares stated at liquidation and redemption value at september 30, 2007 and december 31, 2006, respectively
issued and outstanding series d: zero and 14,669,421 shares stated at liquidation and redemption value at september 30, 2007 and december 31, 2006, respectively
issued and outstanding series e: zero and 13,738,661 shares stated at liquidation and redemption value at september 30, 2007 and december 31, 2006, respectively
preferred stock, .001 par value: authorized 5,000,000 and zero shares at september 30, 2007 and december 31, 2006, respectively. issued and outstanding zero shares at september 30, 2007 and december 31, 2006.
authorized: 100,000,000 and 65,000,000 shares authorized at september 30, 2007 and december 31, 2006, respectively
issued: 26,427,641 and 457,076 shares at september 30, 2007 and december 31, 2006, respectively																																																																										27,000
authorized: zero and 46,408,050 shares at june 30, 2007 and december 31, 2006
issued and outstanding series a: zero and 1,000,000 shares stated at liquidation and redemption value at june 30, 2007 and december 31, 2006, respectively
issued and outstanding series b: zero and 5,945,946 shares stated at liquidation and redemption value at june 30, 2007 and december 31, 2006, respectively
issued and outstanding series c: zero and 10,476,191 shares stated at liquidation and redemption value at june 30, 2007 and december 31, 2006, respectively
issued and outstanding series d: zero and 14,669,421 shares stated at liquidation and redemption value at june 30, 2007 and december 31, 2006, respectively
issued and outstanding series e: zero and 13,738,661 shares stated at liquidation and redemption value at june 30, 2007 and december 31, 2006, respectively
preferred stock, .001 par value: authorized 5,000,000 and zero shares at june 30, 2007 and december 31, 2006, respectively. issued and outstanding zero shares at june 30, 2007 and december 31, 2006
authorized: 100,000,000 and 65,000,000 shares authorized at june 30, 2007 and december 31, 2006, respectively
issued: 26,312,811 and 457,076 shares at june 30, 2007 and december 31, 2006, respectively																																																																											27,000
liabilities, redeemable convertible preferred stock and stockholders’ deficit
authorized: 46,408,050 shares at march 31, 2007 and december 31, 2006
issued and outstanding series a: 1,000,000 shares stated at liquidation and redemption value at march 31, 2007 and december 31, 2006																																																																												1,000,000
issued and outstanding series b: 5,945,946 shares stated at liquidation and redemption value at march 31, 2007 and december 31, 2006																																																																												11,000,000
issued and outstanding series c: 10,476,191 shares stated at liquidation and redemption value at march 31, 2007 and december 31, 2006																																																																												22,000,000
issued and outstanding series d: 14,669,421 shares stated at liquidation and redemption value at march 31, 2007 and december 31, 2006																																																																												35,500,000
issued and outstanding series e: 13,738,661 shares stated at liquidation and redemption value at march 31, 2007 and december 31, 2006																																																																												50,009,000
stockholders’ deficit
common stock .001 par value:
authorized: 65,000,000 shares at march 31, 2007 and december 31, 2006
issued: 485,444 and 457,076 shares at march 31, 2007 and december 31, 2006, respectively																																																																												1,000
total stockholders’ deficit																																																																												-113,075,000
total liabilities and stockholders’ deficit																																																																												47,682,000

Cashflow Statements:

Quarterly

Annual

Unit: USD	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31

cash flows from operating activities
net income	101,600,000	87,600,000	22,500,000	35,400,000	100,700,000	77,500,000	188,600,000	51,500,000	103,300,000	51,900,000	27,300,000	23,800,000				27,800,000	29,200,000	12,600,000			-17,100,000	11,600,000	14,400,000	-2,100,000	4,968,000	852,000	1,402,000	4,378,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	24,400,000	22,000,000	22,300,000	21,700,000	21,500,000	21,300,000	19,200,000	18,800,000	18,800,000	18,700,000	18,100,000	17,200,000	16,200,000	15,900,000	15,800,000	15,300,000	14,900,000	14,500,000	15,200,000	12,800,000	25,700,000	10,900,000	9,900,000	8,900,000	9,116,000	7,758,000	5,891,000	5,135,000	4,392,000	4,123,000	3,609,000	3,522,000	3,321,000	3,826,000	3,384,000	3,323,000	3,359,000	3,629,000	3,423,000	3,422,000	4,432,000	4,292,000	3,681,000	3,433,000	3,055,000	3,068,000	3,030,000	3,070,000	2,947,000	3,096,000	2,859,000	2,904,000	2,938,000	2,594,000	2,654,000	2,844,000	2,820,000	2,836,000
stock-based compensation expense	20,300,000	16,700,000	7,500,000	18,200,000	20,000,000	18,100,000	17,000,000	14,200,000	12,600,000	10,500,000	13,100,000	12,100,000	11,200,000	9,000,000	11,200,000	9,500,000		8,200,000	9,000,000	8,600,000					7,996,000	6,626,000	8,294,000	5,784,000	6,316,000	16,088,000	6,936,000	8,181,000	8,390,000	8,896,000	7,531,000	7,124,000	6,767,000	6,066,000	5,513,000	5,271,000	5,326,000	4,222,000	4,325,000	5,305,000	4,272,000	9,670,000	4,217,000	4,360,000	2,883,000	2,956,000	3,849,000	2,995,000	2,420,000	2,345,000	2,546,000	2,609,000	2,128,000	1,790,000	1,855,000	1,961,000
deferred income taxes	19,500,000	35,700,000			3,900,000	-1,600,000
non-cash interest expense	800,000	800,000	2,100,000	2,500,000	1,900,000	1,600,000	1,800,000	2,000,000	2,100,000	1,600,000	1,500,000	1,500,000	1,500,000	1,500,000	1,300,000	1,500,000		8,400,000							11,326,000	8,902,000	7,749,000	7,623,000	7,492,000	7,363,000	7,264,000	7,163,000																				2,908,000	2,656,000	2,568,000	2,536,000	2,452,000												121,000
loss on extinguishment of debt	0	0	84,400,000	39,500,000														1,500,000																												4,260,000
gain on derivative asset	0
provisions for credit losses	200,000
loss on investments
other	2,000,000	1,000,000	-2,700,000	6,700,000	-200,000	600,000	4,400,000	100,000	100,000	-1,200,000	300,000	700,000	1,700,000	100,000	1,600,000	-600,000	1,000,000	-900,000	-1,000,000	2,100,000	500,000			800,000	-750,000	2,439,000	-263,000	-326,000		-105,000	-176,000	46,000		145,000				7,000	-7,000	139,000
changes in operating assets and liabilities:
accounts receivable	-209,800,000	-1,600,000	-14,600,000	-27,200,000	3,600,000	-9,300,000	-14,700,000	3,500,000	-47,300,000	-25,000,000	-7,900,000	-19,200,000	15,400,000	-3,600,000	-4,800,000	-19,900,000	-35,800,000	-16,000,000	-2,200,000	-17,300,000	4,300,000	-6,100,000	800,000	-14,600,000									-6,565,000	-10,127,000	2,516,000	-12,146,000	9,557,000	-678,000	1,366,000	2,306,000	-15,079,000	-1,590,000	3,415,000	3,461,000	6,678,000	-6,213,000	-6,031,000	-4,503,000	599,000	-2,189,000	-3,781,000	857,000	-4,237,000	-5,389,000	19,000	-3,906,000	-7,419,000	2,741,000	-404,000	1,465,000	-2,197,000	-476,000	-1,196,000	-1,327,000	267,000	-1,998,000	-2,650,000	-2,591,000	-2,348,000	-2,972,000	-3,087,000	-3,012,000	-1,878,000	-1,003,000	-784,000	-821,000
accounts receivable — related party	155,700,000	-17,600,000	-18,900,000	-6,200,000	900,000	-14,300,000	-13,200,000	33,100,000	-39,600,000	3,000,000	-25,300,000	7,100,000	-16,400,000	4,200,000	-16,600,000	-10,100,000
inventories	-5,900,000	0	1,900,000	-6,600,000	6,200,000	-8,300,000	-700,000	-29,600,000	11,700,000	-2,600,000	-24,500,000	-38,200,000	-14,600,000	-10,500,000	-11,000,000	-13,000,000	-46,300,000	-63,100,000	-27,100,000	-17,900,000	-27,600,000	-20,100,000	-7,600,000	4,800,000	-10,154,000	-6,041,000	-11,315,000	-2,690,000	-13,547,000	-17,320,000	-14,665,000	6,706,000	1,261,000	-1,099,000	352,000	1,175,000	-2,816,000	-8,188,000	-10,450,000	-2,649,000	-1,034,000	10,648,000	-3,370,000	-6,966,000	-3,437,000	-897,000	1,684,000	-985,000	-4,069,000	584,000	3,220,000	5,668,000	222,000	1,337,000	-1,723,000	-2,865,000	1,285,000	2,785,000	-1,421,000	-770,000
prepaid expenses and other assets	-26,200,000	-23,900,000	-18,800,000	-12,800,000	-5,100,000	-1,100,000	-15,300,000	-400,000	-17,600,000	-4,700,000	900,000	-20,700,000	-4,700,000	-8,800,000	-16,900,000	-6,400,000	-14,000,000	-2,700,000	-15,900,000	-14,100,000	-15,400,000	-2,800,000	-14,700,000	700,000	-17,017,000	-1,807,000	2,487,000	-5,563,000	-6,343,000	-435,000	-1,499,000	-3,324,000	-2,038,000	372,000	-241,000	-1,421,000	647,000	-1,063,000	-1,743,000	-462,000	-1,502,000	-590,000	248,000	384,000	-580,000	2,248,000	-102,000	-904,000	1,081,000	654,000	-152,000	-1,903,000	1,068,000	-1,241,000	4,000	-729,000
accounts payable	23,600,000	-47,000,000	36,100,000	36,500,000	-17,800,000	-36,400,000	900,000	55,500,000	-52,500,000	-33,000,000	23,000,000	51,500,000	-25,700,000	3,200,000	5,400,000	14,700,000	-21,600,000	10,400,000	-9,400,000	5,000,000
accrued expenses and other liabilities	78,000,000	63,500,000	68,500,000	-48,800,000	21,600,000	43,200,000	51,000,000	-62,400,000	57,600,000	35,900,000	16,200,000	-35,900,000	46,100,000	49,600,000	71,900,000	-33,700,000	29,100,000	600,000	22,700,000	-28,000,000
accrued expenses and other liabilities — related party	-900,000	900,000	-1,100,000	100,000	-8,700,000	3,400,000	-2,700,000	100,000	-4,200,000	800,000	500,000	-600,000	1,900,000	100,000	1,300,000	400,000
net cash from operating activities	183,300,000	125,700,000	196,500,000	63,800,000	147,700,000	98,500,000	96,500,000	87,600,000	45,200,000	56,000,000	44,000,000	500,000	50,700,000	56,700,000	25,300,000	-13,700,000	-25,500,000	-25,800,000	18,300,000	-35,100,000	-1,000,000	62,200,000	26,400,000	-3,600,000	46,933,000	31,190,000	13,910,000	6,367,000	30,439,000	15,855,000	-6,129,000	-4,266,000	21,800,000	23,278,000	17,964,000	-21,835,000	20,070,000	2,677,000	3,681,000	-10,517,000			785,000	-3,488,000	4,607,000	4,822,000	508,000	-1,017,000	-3,518,000	3,694,000	4,372,000	-1,200,000	-5,593,000	-3,449,000	-11,114,000	-8,903,000	-7,668,000	-836,000	-9,082,000	-7,866,000	-7,703,000	-12,864,000	-5,880,000	-9,178,000	-9,858,000	-11,002,000	-15,492,000	-12,971,000	-16,976,000	-23,423,000	-28,101,000	-14,111,000	-16,208,000	-12,765,000	-9,534,000	-11,865,000
cash flows from investing activities
capital expenditures	-135,100,000	-25,600,000	-18,600,000	-12,300,000	-53,600,000	-26,700,000	-22,500,000	-22,100,000	-29,300,000	-20,100,000	-15,700,000	-10,500,000	-64,400,000	-31,100,000	-14,600,000	-12,800,000	-31,800,000	-27,300,000	-19,900,000	-32,900,000	-40,500,000	-36,800,000	-24,800,000	-26,900,000	-49,115,000	7,565,000	0	-45,255,000	-34,795,000	0	-54,563,000	-35,374,000	-29,413,000	-8,745,000	-13,389,000	-25,679,000	-2,910,000	-13,300,000	-2,745,000				-255,000	1,375,000	-2,633,000	-3,108,000	-3,588,000	-2,157,000	-2,790,000	2,915,000	-1,626,000	-1,069,000	-2,055,000	-4,687,000	-2,550,000	-1,699,000	-2,276,000	-3,278,000	-2,663,000	-2,897,000	-2,917,000	-1,646,000	-896,000	-1,090,000	-1,172,000	-1,212,000	-591,000	-165,000	-606,000	-1,617,000	-2,545,000	-5,279,000	-1,749,000	-2,830,000	-3,179,000	-2,331,000
free cash flows	48,200,000	100,100,000	177,900,000	51,500,000	94,100,000	71,800,000	74,000,000	65,500,000	15,900,000	35,900,000	28,300,000	-10,000,000	-13,700,000	25,600,000	10,700,000	-26,500,000	-57,300,000	-53,100,000	-1,600,000	-68,000,000	-41,500,000	25,400,000	1,600,000	-30,500,000	-2,182,000	38,755,000	13,910,000	-38,888,000	-4,356,000	15,855,000	-60,692,000	-39,640,000	-7,613,000	14,533,000	4,575,000	-47,514,000	17,160,000	-10,623,000	936,000				530,000	-2,113,000	1,974,000	1,714,000	-3,080,000	-3,174,000	-6,308,000	6,609,000	2,746,000	-2,269,000	-7,648,000	-8,136,000	-13,664,000	-10,602,000	-9,944,000	-4,114,000	-11,745,000	-10,763,000	-10,620,000	-14,510,000	-6,776,000	-10,268,000	-11,030,000	-12,214,000	-16,083,000	-13,136,000	-17,582,000	-25,040,000	-30,646,000	-19,390,000	-17,957,000	-15,595,000	-12,713,000	-14,196,000
investments in developed software	-5,700,000	-5,500,000	-4,600,000	-3,400,000	-2,400,000	-2,400,000	-2,400,000	-1,900,000	-2,300,000	-2,300,000	-2,400,000	-1,500,000
acquisition of other intangible assets
cash paid for investments					-12,000,000				0	-200,000	-5,000,000	-2,000,000	0	0
net cash from investing activities	-152,800,000	-31,000,000	-23,200,000	-15,700,000	-68,000,000	-29,300,000	-24,900,000	-24,000,000	-31,600,000	-22,600,000	-23,100,000	-42,100,000	-88,400,000	-33,900,000	-21,900,000	-46,900,000	-36,400,000	-12,200,000	-11,400,000	-22,700,000	-51,300,000	-15,300,000	67,200,000	13,400,000	-53,996,000	12,189,000	-39,413,000	7,620,000	-40,785,000	-26,616,000	-61,115,000	-55,988,000	-149,312,000	2,781,000	-21,980,000	-42,286,000	-97,183,000	-45,039,000	-37,242,000	1,454,000	-3,482,000	-7,240,000	-255,000	-4,346,000	-2,633,000	-3,108,000	-3,588,000	-2,157,000	-2,790,000	-1,822,000	-1,626,000	-1,069,000	-2,055,000	-4,687,000	-2,550,000	-1,699,000	-2,276,000	-3,278,000	-40,518,000	-2,897,000	-2,917,000	-1,646,000	-896,000	-1,090,000	-1,172,000	-1,212,000	-591,000	-165,000	-606,000	-1,617,000	-2,545,000	-5,279,000	-1,749,000	-2,830,000	-3,179,000	-2,331,000
cash flows from financing activities
proceeds from issuance of senior unsecured notes, net of issuance costs	0	0	0	440,700,000
proceeds from issuance of term loan b, net of issuance costs	0	0
repayment of term loan b	-1,200,000	-1,300,000	-16,700,000	-1,300,000
repayment of equipment financings	-6,000,000	-5,100,000	-3,600,000	-3,500,000	-3,500,000	-3,300,000	-5,000,000	-7,200,000	-5,000,000	-4,900,000	-5,100,000	-4,800,000	-4,400,000	-4,400,000	-4,300,000	-4,300,000	-8,200,000	-3,200,000	-3,200,000	-3,200,000
repayment of convertible senior notes
financing lease repayments
repayment of mortgage	-59,000,000	-700,000	-600,000	-600,000	-600,000	-600,000	-600,000	-600,000	-500,000	-600,000	-500,000	-600,000	-500,000	-500,000	-600,000	-500,000	-500,000	-500,000	-400,000	-600,000
proceeds from secured borrowing	500,000	13,300,000	20,700,000	15,400,000	12,900,000
repayment of secured borrowing	-15,600,000	-14,200,000	-19,200,000	-13,400,000	-17,600,000
settlement of capped call options	0	88,900,000	52,600,000	23,100,000
repurchase of common stock	0	-29,500,000
proceeds from exercise of stock options	1,800,000	4,600,000	10,100,000	2,500,000	500,000	800,000	1,100,000	5,800,000	3,900,000	100,000	6,300,000	6,000,000	2,600,000	2,400,000	800,000	1,100,000				1,500,000				6,200,000				9,061,000		2,258,000	8,245,000	2,961,000				6,335,000																																								22,000
proceeds from issuance of common stock under employee stock purchase plan	7,800,000	0			5,900,000	0			5,100,000	0			4,500,000	0
payment of withholding taxes in connection with vesting of restricted stock units	-800,000	-2,200,000	-1,700,000	-21,200,000	-600,000	-900,000	-1,100,000	-5,000,000	-100,000	-200,000	-1,500,000	-11,400,000	-100,000	-200,000	-1,200,000	-15,300,000	-600,000	-300,000	-1,200,000	-26,100,000	-2,900,000	-100,000	-1,600,000	-25,200,000				-7,512,000	-3,935,000	-1,155,000	-875,000	-11,816,000	-238,000	-388,000	-289,000	-3,139,000	-27,000	-229,000	-970,000	-1,640,000	-178,000	-41,000	-993,000	-1,434,000	-92,000	-2,683,000	-2,008,000	-3,882,000	-700,000	-134,000	-1,111,000	-1,320,000	-287,000	-65,000	-207,000	-980,000
net cash from financing activities	-72,500,000	-457,000,000	-343,600,000	277,800,000	-20,900,000	7,800,000	-900,000	-14,100,000	2,200,000	-6,900,000	3,200,000	-12,100,000	-14,500,000	-3,900,000	-1,600,000	-20,300,000	-1,500,000			-28,400,000	130,100,000	10,500,000	483,900,000	-19,000,000	-202,445,000	258,198,000	16,198,000	1,549,000	-1,584,000	1,091,000	698,000	-8,870,000	297,897,000	2,456,000	1,267,000	2,927,000	-991,000	182,150,000	-2,408,000	-2,184,000	-663,000	-956,000	-1,001,000	2,249,000	2,847,000	-30,887,000	33,011,000	-939,000	2,130,000	1,089,000	133,000	93,041,000	1,498,000	1,435,000	802,000	-347,000	87,000	1,180,000	51,858,000	1,977,000	19,976,000	357,000	6,509,000	610,000	66,332,000	32,546,000	281,000	24,637,000	111,000	66,000	56,719,000	-2,163,000	8,332,000	-10,000	113,455,000	41,000
effect of exchange rate changes on cash and cash equivalents	700,000	-1,900,000	8,900,000	3,800,000		4,600,000	-900,000	-2,500,000
net increase in cash, cash equivalents, and restricted cash
cash, cash equivalents, and restricted cash, beginning of year
cash and cash equivalents, end of year
supplemental cash flow information
unrealized loss on investments
repayment of convertible debt		-510,700,000	-377,600,000	-163,900,000													-100,000	0							-209,992,000
net increase in cash and cash equivalents																																					-78,228,000								4,821,000	-29,173,000	29,931,000	-4,113,000	-4,178,000	2,961,000	2,879,000	90,772,000									9,356,000			-9,658,000	55,302,000	20,332,000	-15,802,000	11,501,000	-17,471,000				-9,625,000	-15,605,000	100,742,000	-14,155,000
cash and cash equivalents at beginning of period		0	0	953,400,000
cash and cash equivalents at end of period		-364,200,000	-161,500,000	1,283,100,000
supplemental noncash information:
purchases of property and equipment included in accounts payable and accrued expenses		-1,400,000	1,000,000	3,500,000						2,200,000	500,000	5,100,000		1,100,000	-2,900,000	7,800,000		-2,400,000	1,500,000	4,100,000		200,000	-3,900,000	8,400,000		7,565,000
purchases of property, plant and equipment included in long-term debt		0	1,100,000	2,400,000						5,900,000
additions to right-of-use assets resulting from new operating lease liabilities
provision for credit losses			300,000	4,800,000		0	-600,000	1,200,000	200,000	100,000	800,000	1,200,000	1,100,000	1,200,000	1,100,000	800,000	300,000	700,000	200,000	1,900,000	200,000	500,000	2,000,000	600,000
financing lease payments
net increase in cash, cash equivalents and restricted cash			-161,500,000	329,700,000		81,600,000	69,800,000	47,000,000										2,000,000				59,000,000	577,700,000	-12,300,000		300,015,000	-9,387,000	15,348,000
benefit from credit losses
unrealized gain on investments
acquisition of a business									0	0	0	-3,000,000
proceeds from issuance of term loan, net of issuance costs					0
repayment of term loan					-1,200,000	-133,500,000	-1,200,000	-1,300,000	-1,200,000	-1,300,000	-1,200,000	-1,300,000	-1,300,000	-1,200,000	-1,200,000	-1,300,000
effect of exchange rate changes on cash									3,000,000			-100,000	4,800,000	-5,600,000	-2,900,000	-600,000	-1,600,000	-2,200,000	-1,400,000	-300,000	6,100,000	1,600,000	200,000	-3,100,000	3,332,000	-1,562,000	-82,000	-188,000	-727,000	-13,000	-354,000	-307,000	-41,000	230,000	199,000	58,000	-124,000	-47,000	-5,000	210,000	-55,000
cash, cash equivalents, and restricted cash, end of year
acquisition of intangible assets										0	0	-25,100,000	-11,100,000	-2,800,000	-4,500,000	-3,100,000	-5,100,000	-1,900,000	-3,300,000	-500,000	-29,200,000	-7,800,000	0	-500,000	-810,000	-1,425,000
repayment of financing lease						-100,000	-100,000	-5,800,000
cash, cash equivalents and restricted cash at beginning of period						0	0	704,200,000		0	0	689,700,000		0	0	806,400,000		0	0	922,000,000		0	0	213,700,000		0
cash, cash equivalents and restricted cash at end of period						81,600,000	69,800,000	751,200,000		25,300,000	24,200,000	635,900,000		13,300,000	-1,100,000	724,900,000		2,000,000	33,900,000	835,500,000		59,000,000	577,700,000	201,400,000		300,015,000
loss on extinguishment of convertible debt
receipts from the maturity or sale of marketable securities
proceeds from equipment financings
payment of debt issuance costs																	0	0
prepayments of financing lease obligation
net decrease in cash, cash equivalents and restricted cash										25,300,000	24,200,000	-53,800,000		13,300,000	-1,100,000	-81,500,000				-86,500,000										-9,683,000
purchases of developed software included in accounts payable and accrued expenses										300,000	-400,000	800,000
operating lease liabilities arising from obtaining right-of-use assets
finance lease liability arising from obtaining right-of-use assets
lease liabilities arising from obtaining right-of-use assets											4,900,000	100,000		100,000	10,400,000	1,600,000	200,000			500,000
cash paid for marketable securities
proceeds from mortgage, net of issuance costs
proceeds from issuance of common stock																																												4,876,000									1,785,000	1,500,000
net loss														-5,200,000																1,659,000	-1,691,000	-6,569,000	-6,860,000	-2,227,000	-7,767,000	-9,977,000	-9,119,000	-3,081,000	-4,198,000	-12,481,000	-27,327,000	-18,927,000	-15,432,000	-11,834,000	-5,400,000	-10,845,000	-29,111,000	-6,144,000	-2,500,000	-21,290,000	-10,519,000	-10,665,000	-10,194,000	-12,417,000	-14,476,000	-14,780,000	-14,339,000	-13,562,000	-19,421,000	-9,848,000	-20,858,000	-12,100,000	-14,346,000	-13,855,000	-14,932,000	-24,725,000	-20,239,000	-19,645,000	-28,283,000	-20,752,000	-23,882,000	-19,874,000	-15,668,000	-13,639,000	-12,672,000	-11,560,000
adjustments to reconcile net loss to net cash from operating activities:
acquisition														0	0	-26,000,000
proceeds from issuance of convertible debt, net of issuance costs
proceeds from equipment financing
purchases of intangible assets included in accounts payable and accrued expenses														-1,600,000	-400,000	2,800,000	-4,100,000	3,800,000	2,100,000	1,400,000
cash paid for investment																-5,000,000
non-cash interest																				11,800,000	11,600,000	11,300,000	11,200,000	11,100,000															2,008,000	1,984,000
stock-based compensation																					15,600,000	6,600,000	5,800,000	7,900,000
proceeds from the maturity or sale of investments
purchases of investments																					0	0	100,000	-38,000,000	-86,696,000	-24,839,000	-36,909,000	-2,156,000	-45,849,000	-27,635,000	-57,060,000	-60,880,000	-182,909,000	-21,673,000
proceeds from equipment financings, net of issuance costs
purchase of capped call options																									-40,000
cash paid for interest, net of amount capitalized
cash paid for taxes
purchases of property, plant and equipment included in accounts payable and accrued expenses
receipts from the maturity or sale of investments																		17,000,000	11,800,000	10,700,000	18,400,000	29,300,000	91,900,000	78,800,000	82,625,000	61,089,000	49,155,000	55,031,000	39,859,000	38,641,000	50,508,000	40,266,000	63,010,000	33,199,000
proceeds from issuance of debt																		0
repayment of debt																																																		0
proceeds from issuance of common stock, net of issuance costs																					0	0
proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan																		4,400,000			6,900,000	10,600,000			7,955,000	17,255,000
proceeds from mortgage, net of issuance cost
proceeds from issuance of convertible debt, net of issuance cost
accounts payable, accrued expenses and other current liabilities																						50,000,000	6,500,000	-20,400,000	38,750,000	1,199,000	1,507,000	-5,256,000	18,249,000	20,811,000	3,077,000	-20,950,000	16,811,000	17,910,000	6,818,000	-14,226,000	1,271,000	465,000	7,679,000	-8,776,000	6,204,000	6,785,000	5,056,000	-59,000	-3,336,000	-500,000	3,444,000	917,000	-6,297,000	13,417,000
other liabilities																						0	-1,100,000	-1,300,000		4,030,000
proceeds from issuance of convertible notes, net of issuance costs																																					-179,000
supplemental cash flow information:
provision for bad debts																									1,856,000	675,000	1,162,000	807,000	794,000	1,002,000	889,000	697,000	420,000	780,000	427,000	295,000	181,000	815,000	419,000	655,000	-1,578,000	1,582,000	852,000	328,000	585,000	865,000	913,000	891,000	799,000	1,374,000	1,241,000	1,327,000	1,088,000	835,000	587,000	899,000	1,465,000	894,000	439,000	367,000	798,000	834,000	602,000	1,083,000	2,200,000	1,150,000	432,000	1,238,000	2,252,000	890,000	550,000	572,000	438,000	293,000	269,000	120,000
accounts and unbilled receivable
deferred revenue																									1,153,000	657,000	179,000	11,000	-1,026,000	-135,000	-461,000	-2,165,000	524,000	493,000	131,000	-87,000	133,000	38,000	-138,000	-882,000	106,000	169,000	221,000	313,000	720,000	-421,000	643,000	-288,000	333,000	-333,000	-761,000	-3,784,000	4,307,000	-10,000	-1,483,000	49,000	389,000	-1,532,000	1,883,000	-2,405,000													639,000	-52,000	84,000	395,000
other long-term liabilities																												-740,000	2,683,000	168,000	-395,000	627,000	534,000	191,000	366,000	111,000	44,000	-9,000	-191,000	956,000	814,000	223,000	-117,000	264,000	194,000	1,059,000	-463,000	41,000	-624,000	321,000	60,000	319,000	-203,000	2,000	28,000	-12,000
principal payments of capital lease obligations																																	0	0	0	-269,000	-791,000	-1,255,000	-2,132,000	-1,340,000	-1,293,000	-1,469,000	-1,621,000	-1,193,000	-1,684,000	-912,000	-644,000	-618,000
cash and cash equivalents, beginning of year																																																																									0	0
loss on extinguishment of long-term debt																																					0
accounts receivable and unbilled receivable																										-551,000	-2,610,000	-2,796,000		-17,364,000	-9,017,000	1,800,000
payments for taxes related to net share settlement of equity awards																										-291,000
additions to rou assets resulting from new operating lease liabilities
adjustments to reconcile net income to net cash from operating activities
purchases of property, equipment
non-cash investing and financing activities:
purchases of property, equipment and intangible assets																												-45,255,000	-34,795,000
cash, cash equivalents and restricted cash, beginning of period																												113,906,000		0
cash, cash equivalents and restricted cash, end of period																												129,254,000		-9,683,000
impairments and other
proceeds from divestiture of business																																					0	0	1,100,000	4,614,000
repayment of convertible notes																															-6,672,000	-15,000					0
cash, cash equivalents and restricted cash, beginning of year
cash, cash equivalents and restricted cash, end of year
supplemental disclosure of cash flow information
non-cash investing and financing activities
allocation to equity for conversion feature for issuance of 1.375% convertible notes
allocation to equity for conversion feature for issuance of 1.25% convertible notes
allocation to equity for conversion feature for the repurchase of 2% convertible notes
adjustments to reconcile net loss to net cash from operating activities
purchases of property, equipment and software																															-54,563,000	-35,374,000	-29,413,000	-8,745,000	-13,389,000	-25,679,000
net decrease in cash and cash equivalents																																-69,431,000			-2,550,000	-61,136,000			-35,974,000	-11,037,000				-5,585,000									-6,150,000	-6,701,000	-12,862,000	-10,949,000		-2,934,000	2,258,000	-8,786,000											26,073,000	-21,553,000
cash, cash equivalents, beginning of period																																272,577,000
cash, cash equivalents, end of period																																203,146,000
acquisition of business
cash paid for interest																																																									2,889,000	0			3,729,000	696,000	2,981,000	681,000	2,746,000	1,195,000			2,272,000	0	1,038,000	708,000	786,000	896,000
purchases of property and equipment under capital lease																																									0	0	0	5,721,000	0				0	4,737,000
non-cash interest and other expense																																		4,118,000	4,073,000	3,994,000					1,957,000	1,932,000	1,906,000	1,883,000	1,856,000	2,528,000	3,341,000	2,528,000	1,330,000	2,593,000
proceeds from exercise of stock options and issuance of common stock																																		2,844,000
cash and cash equivalents, beginning of period																																		0	0	137,174,000	0	0	0	122,672,000	0	0	0	151,193,000		0	0	149,727,000		0	0	57,293,000		0	0	93,955,000		0	0	113,274,000		0	0	127,996,000		0	0	56,663,000		0	0	94,588,000				33,231,000
cash and cash equivalents, end of period																																		28,745,000	-2,550,000	76,038,000	-78,228,000	139,741,000	-35,974,000	111,635,000	-22,795,000	330,000	-471,000	145,608,000		-29,173,000	29,931,000	145,614,000		2,961,000	2,879,000	148,065,000		-6,701,000	-12,862,000	83,006,000		-2,934,000	2,258,000	104,488,000		-14,153,000	-267,000	118,338,000		20,332,000	-15,802,000	68,164,000	-17,471,000	-24,974,000	26,073,000	73,035,000	-9,625,000	-15,605,000	100,742,000	19,076,000
purchases of short-term investments																																				-41,347,000	-101,413,000	-40,644,000
receipts from the maturity or sale of short-term investments																																				24,740,000
impairment and other charges																																																	0
purchases of property and equipment																																					-2,910,000	-13,300,000	-2,745,000	-3,160,000	-3,482,000	-2,525,000	-255,000	-4,346,000	-2,633,000	-3,108,000	-3,588,000	-2,157,000	-2,790,000	-1,822,000	-1,626,000	-1,069,000	-2,055,000	-4,687,000	-2,550,000	-1,699,000	-2,276,000	-3,278,000	-2,663,000	-2,897,000	-2,917,000	-1,646,000	-896,000	-1,090,000	-1,172,000	-1,212,000	-591,000	-165,000	-606,000	-1,617,000	-2,545,000	-5,279,000	-1,749,000	-2,830,000	-3,179,000	-2,331,000
acquisition of canadian distribution business																																									0
proceeds from issuance of common stock, net of offering costs																																					6,000	3,358,000	694,000	796,000	808,000	554,000			4,709,000	1,538,000	1,778,000	3,561,000
allocation to equity for conversion feature for issuance of 2% convertible notes
common stock issued in exchange for 3.75% convertible notes
receipts from the sale of short-term investments
allocation to equity for conversion feature for issuance of convertible notes
allocation to equity for conversion feature for the repurchase of convertible notes
proceeds from issuance of long-term debt, net of issuance costs																																													-86,000	6,000											-80,000	-74,000
repayment of long-term debt																																													0	-28,836,000
allocation to equity for conversion feature for the 2% notes																																													0	0
common stock issued in exchange for 3.75% convertible senior notes
net cash provided operating activities
net (decrease) in cash and cash equivalents
non-cash financing activities
common stock issued in exchange for senior convertible notes
common stock issued in exchange for 5.375% convertible senior notes																																																	0	0
deferred tax provision
acquisition of neighborhood diabetes																																																									0	0
principal payment of long-term debt
issuance of common stock for the acquisition of neighborhood diabetes																																																									0	0
payments for capital lease obligations
net proceeds from issuance of common stock																																																		1,559,000	3,244,000	94,361,000
accounts payable, accrued expenses, and other liabilities																																																				-1,826,000	-5,658,000	5,927,000	-1,806,000	4,536,000	2,845,000	-318,000
restructuring and impairment of assets
proceeds from issuance of long-term debt
payment of transaction fees related to the credit facility amendment
payments to retire long-term debt																																																										0
proceeds from exercise of warrants
proceeds from issuance of common stock, net of offering expenses																																																								633,000	167,000	1,254,000	1,116,000	1,977,000		357,000	6,977,000	610,000		27,544,000	281,000	124,000	159,000	149,000	550,000	555,000	11,049,000	-10,000
amortization of debt discount																																																									2,220,000	2,142,000	1,425,000	1,424,000	7,754,000	1,887,000	2,386,000	1,238,000	1,077,000	7,823,000	1,633,000	1,039,000	0	0	538,000	58,000	60,000	60,000	59,000	60,000
principal payments of long term debt																																																																								-2,727,000
allocation of fair value of warrants from net proceeds from issuance of facility agreement																																																																	0	0	0	6,065,000
non cash interest expense																																																										146,000	2,114,000	121,000	1,125,000	214,000	308,000	132,000	130,000	1,438,000			178,000	172,000			0	0	0	-57,000
impairment of assets
prepaid expenses and other current assets																																																										1,285,000	496,000	-930,000
other long term liabilities																																																										-43,000	-189,000	-127,000	-109,000	-229,000	-7,000	-35,000	-1,000	-216,000	-237,000	172,000	126,000	113,000	102,000	2,115,000	103,000	94,000	917,000	1,000
payment of transaction fees related to credit facility amendment
depreciation																																																												1,163,000	1,131,000	1,250,000	1,258,000	1,438,000	1,221,000	1,370,000	1,325,000	1,306,000	1,710,000	1,781,000	1,526,000	1,358,000		1,333,000	1,173,000	846,000
accounts payable and accrued expenses																																																												-287,000	-1,912,000	-2,325,000	5,535,000	-2,437,000	1,273,000	1,071,000	-3,572,000	2,715,000	281,000	-301,000	-84,000	4,929,000	1,089,000	-420,000	-673,000	1,369,000
unissued restricted stock units																																																												-538,000
stock based compensation expense
other assets																																																													-1,000								-8,000	0	-41,000	50,000	69,000	68,000	1,129,000	-1,675,000
net proceeds from issuance of debt
proceeds from payment of subscription receivable																																																																					0	0	0	9,000				19,000
stock compensation expense																																																														1,272,000	1,374,000	1,311,000	1,017,000	954,000	1,030,000	1,201,000	750,000	960,000	984,000	674,000	581,000	432,000	298,000	209,000
non cash impairment charges
inventory																																																																3,486,000	-1,852,000	1,234,000	4,738,000	1,723,000	-403,000	-3,131,000	-5,830,000	484,000	-3,418,000	-443,000	127,000	-866,000
prepaids and other current assets																																																																-769,000	-767,000	536,000	1,284,000	-357,000	493,000	-773,000	95,000	-1,452,000	372,000	-515,000	549,000	30,000
deferred revenue, short term																																																														-992,000				361,000				590,000	344,000	-13,000
net proceeds from facility agreement
repayment of long term loan
proceeds from issuance of facility agreement, net of financing expenses																																																																		32,502,000	0	24,513,000
deferred revenue, short-term																																																																557,000				107,000
redeemable convertible preferred stock warrant expense																																																																									0	0	-10,000	84,000
redemption of long term loan																																																																						0
conversion of preferred stock to common stock upon initial public offering																																																																									0	0
principal payments of long term loan																																																																						0
proceeds from convertible note offering, net of financing expenses
principal payments of long-term loan
decrease in restricted cash
proceeds from sale of series e preferred stock, net of issuance cost
accretion of redeemable convertible preferred stock
loss on impairment and disposal of assets
net proceeds from convertible note offering																																																																						-83,000
adjustments to reconcile net loss to net cash from operating activities depreciation
principal payments under capital lease
gain/ loss on disposal of assets
loss on impairment of assets

Insulet Corporation(NASDAQ:PODD)

Insulet Corporation
(NASDAQ:PODD)